10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________

FORM 10-Q

______________________

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

______________________

Hyzon Motors Inc.

(Exact name of registrant as specified in its charter)

______________________

Delaware	001-39632	82-2726724
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

475 Quaker Meeting House Road Honeoye Falls, NY	14472
(Address of principal executive offices)	(Zip Code)

(585)-484-9337

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

______________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	HYZN	NASDAQ Capital Market
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share	HYZNW	NASDAQ Capital Market

______________________

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  o    No  x

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  o   No  x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	x	Smaller reporting company	x
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act.    o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  x

As of March 31, 2023, 244,561,073 shares of Class A Common Stock, par value $0.0001 per share, were issued and outstanding.

1

CAUTIONARY NOTE REGARDING FORWARD- LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements include, without limitation, statements regarding the financial position, business strategy, plans and objectives of management for future operations, and any statements that refer to characterizations of future events or circumstances, including any underlying assumptions. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this report, the words “could,” “should”, “will,” “may,” “anticipate,” “believe,” “expect,” “estimate,” “intend,” “plan,” “project,” the negative of such terms, and other similar expressions are intended to identify forward looking statements, although not all forward-looking statements contain such identifying words. Such forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events.

Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, those described below and under the section entitled “Risk Factors” included in our Annual Report filed on Form 10-K for the year ended December 31, 2021, as amended by Amendment No. 1 on Form 10-K/A filed with the Securities and Exchange Commission (“SEC”) on March 14, 2023, and in subsequent reports that we file with the SEC, including this Form 10-Q for the quarter ended September 30, 2022:

•our ability to commercialize our products and strategic plans, including our ability to establish facilities to produce our vehicles or secure hydrogen supply in appropriate volumes, at competitive costs or with competitive emissions profiles;

•our ability to effectively compete in the heavy-duty transportation sector, and withstand intense competition and competitive pressures from other companies worldwide in the industries in which we operate;

•our ability to convert non-binding memoranda of understanding and letters of intent into binding orders or sales (including because of current or prospective resources of our counterparties) and the ability of our counterparties to make payments on orders;

•our ability to invest in hydrogen production, distribution, and refueling operations to supply our customers with hydrogen at competitive costs to operate their fuel cell electric vehicles;

•disruptions to the global supply chain, including as a result of the COVID-19 pandemic, the war in Ukraine and geopolitical events, and shortage of raw materials, and the related impacts on our third party suppliers and assemblers;

•our ability to maintain the listing of our common stock on NASDAQ;

•our ability to raise financing in the future;

•our ability to retain or recruit, or changes required in, our officers, key employees or directors;

•cybersecurity threats and breaches and compliance with privacy and data protection laws;

•our ability to protect, defend, or enforce intellectual property on which we depend; and

•the impacts of legal proceedings, regulatory disputes and governmental inquiries.

Should one or more of the risks or uncertainties described above, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements.

The forward-looking statements contained in this report are based on our current expectations and beliefs concerning future developments and their potential effects on us and speak only as of the date of this report. Except as otherwise required by applicable law, we disclaim any duty to update any forward looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this report. You should, however, review additional disclosures we make in subsequent filings with the SEC.

2

Hyzon Motors, Inc.

Quarterly Report on Form 10-Q

Table of Contents

		Page No.
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements	4
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	36
Item 4.	Controls and Procedures	37
PART II – OTHER INFORMATION		40
Item 1.	Legal Proceedings	40
Item 1A.	Risk Factors	40
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	41
Item 3.	Defaults Upon Senior Securities	41
Item 4.	Mine Safety Disclosures	41
Item 5.	Other Information	41
Item 6.	Exhibits	42
SIGNATURES		43

3

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

(unaudited)

	September 30, 2022		December 31, 2021
ASSETS
Current assets
Cash and cash equivalents	$	70,602	$	445,146
Short-term investments	239,648		—
Accounts receivable	48		2,956
Related party receivable	64		264
Inventory	39,825		20,927
Prepaid expenses and other current assets	24,070		26,852
Total current assets	374,257		496,145
Property, plant, and equipment, net	24,869		14,346
Right-of-use assets	9,250		10,265
Investments in equity securities	15,030		4,948
Other assets	7,690		4,575
Total Assets	$	431,096	$	530,279
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	$	8,033	$	7,980
Accrued liabilities	18,586		6,770
Related party payables	399		3,695
Contract liabilities	784		10,925
Current portion of lease liabilities	2,212		1,886
Total current liabilities	30,014		31,256
Long term liabilities
Lease liabilities	7,585		8,830
Private placement warrant liability	1,843		15,228
Earnout liability	16,390		103,761
Deferred income taxes	526		—
Other liabilities	5,774		1,139
Total liabilities	62,132		160,214
Commitments and contingencies (Note 12)
Stockholders’ Equity
Common stock, $0.0001 par value; 400,000,000 shares authorized, 248,153,362 and 247,758,412 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.	25		25
Additional paid-in capital	404,436		400,826
Accumulated deficit	(15,731)		(26,412)
Accumulated other comprehensive (loss) income	(300)		378
Total Hyzon Motors Inc. stockholders’ equity	388,430		374,817
Noncontrolling interest	(19,466)		(4,752)
Total Stockholders’ Equity	368,964		370,065
Total Liabilities and Stockholders’ Equity	$	431,096	$	530,279

The accompanying notes are an integral part of these unaudited consolidated financial statements.

4

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(in thousands, except per share amounts)

(unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Revenue	$	5	$	89	$	2,939	$	89
Operating expense:
Cost of revenue	8,203		204		10,226		204
Research and development	9,241		3,982		26,660		8,081
Selling, general, and administrative	36,103		42,661		75,920		51,607
Total operating expenses	53,547		46,847		112,806		59,892
Loss from operations	(53,542)		(46,758)		(109,867)		(59,803)
Other income (expense):
Change in fair value of private placement warrant liability	3,447		7,614		13,385		7,614
Change in fair value of earnout liability	18,034		73,359		87,371		73,359
Gain (loss) on equity securities	—		—		10,082		—
Foreign currency exchange loss and other income	(3,871)		(116)		(6,475)		(175)
Interest income (expense), net	279		(254)		350		(5,249)
Total other income (expense)	17,889		80,603		104,713		75,549
Net income (loss) before income taxes	(35,653)		33,845		(5,154)		15,746
Income tax expense	—		—		526		—
Net income (loss)	$	(35,653)	$	33,845	$	(5,680)	$	15,746
Less: Net loss attributable to noncontrolling interest	(10,858)		(776)		(16,361)		(1,307)
Net income (loss) attributable to Hyzon	$	(24,795)	$	34,621	$	10,681	$	17,053
Comprehensive income (loss):
Net income (loss)	$	(35,653)	$	33,845	$	(5,680)	$	15,746
Foreign currency translation adjustment	862		(187)		838		(273)
Unrealized gain on short-term investments	131		—		131		—
Comprehensive income (loss)	$	(34,660)	$	33,658	$	(4,711)	$	15,473
Less: Comprehensive loss attributable to noncontrolling interest	(9,705)		(749)		(14,714)		(1,269)
Comprehensive income (loss) attributable to Hyzon	$	(24,955)	$	34,407	$	10,003	$	16,742
Net income (loss) per share attributable to Hyzon:
Basic	$	(0.10)	$	0.15	$	0.04	$	0.09
Diluted	$	(0.10)	$	0.14	$	0.04	$	0.08
Weighted average common shares outstanding:
Basic	248,164		234,091		248,054		189,101
Diluted	248,164		246,480		257,828		200,984

The accompanying notes are an integral part of these unaudited consolidated financial statements.

5

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(in thousands, except share data)

(unaudited)

	Legacy Common Stock			Common Stock Class A			Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Total Hyzon Motors Inc. Stockholders’ Equity (Deficit)		Noncontrolling Interest		Total Stockholders’ Equity (Deficit)
	Shares	Amount		Shares	Amount
Balance as of December 31, 2021	—	$	—	247,758,412	$	25	$	400,826	$	(26,412)	$	378	$	374,817	$	(4,752)	$	370,065
Exercise of stock options	—	—		35,324	—		40		—		—		40		—		40
Stock-based compensation	—	—		—	—		3,052		—		—		3,052		—		3,052
Vesting of RSUs	—	—		168,772	—		—		—		—		—		—		—
Net share settlement of equity awards	—	—		—	—		(463)		—		—		(463)		—		(463)
Common stock issued for the cashless exercise of warrants	—	—		44,349	—		—		—		—		—		—		—
Repurchase of warrants	—	—		—	—		(31)		—		—		(31)		—		(31)
Net income attributable to Hyzon	—	—		—	—		—		35,476		—		35,476		—		35,476
Net loss attributable to noncontrolling interest	—	—		—	—		—		—		—		—		(5,503)		(5,503)
Foreign currency translation income (loss)	—	—		—	—		—		—		(518)		(518)		494		(24)
Balance as of June 30, 2022	—	—		248,006,857	25		403,424		9,064		(140)		412,373		(9,761)		402,612
Exercise of stock options	—	—		3,544	—		4		—		—		4		—		4
Stock-based compensation	—	—		—	—		1,063		—		—		1,063		—		1,063
Vesting of RSUs	—	—		133,980	—		—		—		—		—		—		—
Net share settlement of equity awards	—	—		—	—		(55)		—		—		(55)		—		(55)
Common stock issued for the cashless exercise of warrants	—	—		8,981	—		—		—		—		—		—		—
Unrealized gain on short-term investments	—	—		—	—		—		—		131		131		—		131
Net loss attributable to Hyzon	—	—		—	—		—		(24,795)		—		(24,795)		—		(24,795)
Net loss attributable to noncontrolling interest	—	—		—	—		—		—		—		—		(10,858)		(10,858)
Foreign currency translation income (loss)	—	—		—	—		—		—		(291)		(291)		1,153		862
Balance as of September 30, 2022	—	$	—	248,153,362	$	25	$	404,436	$	(15,731)	$	(300)	$	388,430	$	(19,466)	$	368,964

The accompanying notes are an integral part of these unaudited consolidated financial statements.

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(in thousands, except share data)

(unaudited)

	Legacy Common Stock			Common Stock Class A			Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Loss		Total Hyzon Motors Inc. Stockholders’ Equity (Deficit)		Noncontrolling Interest		Total Stockholders’ Equity (Deficit)
	Shares	Amount		Shares	Amount
Balance as of December 31, 2020	93,750,000	$	94	—	$	—	$	29,045	$	(14,271)	$	(16)	$	14,852	$	(91)	$	14,761
Retroactive application of recapitalization	(93,750,000)	(94)		166,125,000	17		77		—		—		—		—		—
Adjusted balance, beginning of period	—	—		166,125,000	17		29,122		(14,271)		(16)		14,852		(91)		14,761
Exercise of stock options	—	—		132,900	—		190		—		—		190		—		190
Stock-based compensation	—	—		—	—		816		—		—		816		—		816
IP transaction - deemed distribution	—	—		—	—		(10,000)		—		—		(10,000)		—		(10,000)
Net loss attributable to Hyzon	—	—		—	—		—		(17,568)		—		(17,568)		—		(17,568)
Net loss attributable to noncontrolling interest	—	—		—	—		—		—		—		—		(531)		(531)
Foreign currency translation income (loss)	—	—		—	—		—		—		(79)		(79)		11		(68)
Balance at June 30, 2021	—	—		166,257,900	17		20,128		(31,839)		(95)		(11,789)		(611)		(12,400)
Reverse recapitalization transaction, net	—	—		73,502,303	7		351,498		—		—		351,505		—		351,505
Issuance of common stock	—	—		7,234,006	1		(1)		—		—		—		—		—
Vesting of RSUs	—	—		284,796	—		—		—		—		—		—		—
Exercise of stock options	—	—		221,500	—		250		—		—		250		—		250
Stock-based compensation	—	—		—	—		28,146		—		—		28,146		—		28,146
Net income attributable to Hyzon	—	—		—	—		—		34,621		—		34,621		—		34,621
Net loss attributable to noncontrolling interest	—	—		—	—		—		—		—		—		(776)		(776)
Foreign currency translation income (loss)	—	—		—	—		—		—		(232)		(232)		27		(205)
Balance as of September 30, 2021	—	$	—	247,500,505	$	25	$	400,021	$	2,782	$	(327)	$	402,501	$	(1,360)	$	401,141

The accompanying notes are an integral part of these unaudited consolidated financial statements.

6

HYZON MOTORS INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

	Nine Months Ended September 30,
	2022			2021
Cash Flows from Operating Activities:
Net income (loss)	$	(5,680)		$	15,746
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	2,445			671
Stock-based compensation	4,115			29,023
Loss on extinguishment of convertible notes	—			107
Deferred income tax expense	526			—
Accretion of discount on available-for-sale securities	(185)			—
Noncash interest expense	—			5,449
Fair value adjustment of private placement warrant liability	(13,385)			(7,614)
Fair value adjustment of earnout liability	(87,371)			(73,359)
(Gain) loss on equity securities	(10,082)			—
Equity method investment loss	72			—
Changes in operating assets and liabilities:
Accounts receivable	2,676			(5,712)
Inventory	(16,776)			(12,008)
Prepaid expenses and other current assets	1,621			(19,638)
Other assets	(383)			(150)
Accounts payable	289			3,371
Accrued liabilities	11,678			3,082
Related party payables, net	31			3,821
Contract liabilities	(5,053)			4,845
Other liabilities	(756)			124
Net cash used in operating activities	(116,218)			(52,242)
Cash Flows from Investing Activities:
Purchases of property and equipment	(11,320)			(8,810)
Advanced payments for capital expenditures	—			(3,999)
Purchases of short-term investments	(313,032)			—
Proceeds from maturities of short-term investments	73,700			—
Investment in equity securities	—			(4,826)
Net cash used in investing activities	(250,652)			(17,635)
Cash Flows from Financing Activities:
Proceeds from Business Combination, net of redemption and transaction costs	—			508,993
Exercise of stock options	44			440
Payment of finance lease liability	(294)			(135)
Debt issuance costs	—			(133)
Proceeds from issuance of convertible notes	—			45,000
Net share settlement of equity awards	(517)			—
Payment under Horizon IP agreement	(3,146)			—
Repurchase of warrants	(31)			—
Net cash (used in) provided by financing activities	(3,944)			554,165
Effect of exchange rate changes on cash	(967)		—	(853)
Net change in cash, cash equivalents, and restricted cash	(371,781)			483,435
Cash, cash equivalents, and restricted cash — Beginning	449,365			17,139
Cash, cash equivalents, and restricted cash — Ending	$	77,584		$	500,574
Supplemental schedule of non-cash investing activities and financing activities:
Lease assets obtained in exchange for lease obligations:
Operating leases	—			6,803
Finance leases	—			—
Conversion of Legacy Hyzon common stock	—			73
Recognition of earnout liability in Business Combination	—			188,373
Recognition of private placement warrant liability in Business Combination	—			19,395
Horizon license agreement payable	—			10,000
Conversion of convertible notes for common stock	—			50,198

The accompanying notes are an integral part of these unaudited consolidated financial statements.

7

HYZON MOTORS INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Nature of Business and Basis of Presentation

Description of Business

Hyzon Motors Inc. (“Hyzon” or the “Company”), headquartered in Honeoye Falls, New York, is commercializing its proprietary heavy-duty fuel cell technology through manufacturing and retrofitting heavy-duty hydrogen fuel cell electric vehicles (“FCEVs”) in the United States, Europe, and Australia. In addition, Hyzon builds and fosters a clean hydrogen supply ecosystem with leading partners from feedstocks through production, dispensing, and financing. The Company is majority-owned by Hymas Pte. Ltd. (“Hymas”), a Singapore company, which is majority-owned but indirectly controlled by Horizon Fuel Cell Technologies PTE Ltd., a Singapore company (“Horizon”).

Business Combination and Basis of Presentation

The accompanying unaudited interim consolidated financial statements and related disclosures have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the requirements and rules of the SEC regarding interim reporting. Certain notes or other information that are normally required by U.S. GAAP have been omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited interim consolidated financial statements should be read in connection with the Company’s audited consolidated financial statements and related notes included in the Company’s amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021.

The Company’s unaudited interim consolidated financial statements include the accounts and operations of the Company and its wholly owned subsidiaries including variable interest entity arrangements in which the Company is the primary beneficiary. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited interim consolidated financial statements include all normal and recurring adjustments necessary for a fair presentation for the periods presented. Results of operations reported for interim periods presented are not necessarily indicative of results for the entire year or any other periods.

On July 16, 2021 (the “Closing Date”), legacy Hyzon Motors Inc. and now named Hyzon Motors USA Inc., (“Legacy Hyzon”), consummated the transactions contemplated by the Business Combination Agreement and Plan of Reorganization (the “Business Combination”), dated February 8, 2021, with Decarbonization Plus Acquisition Corporation (“DCRB”) to effect a business combination between DCRB and Legacy Hyzon with DCRB Merger Sub Inc., a wholly owned subsidiary of DCRB, merging with and into Legacy Hyzon, with Legacy Hyzon surviving the merger as a wholly owned subsidiary of DCRB. On the Closing Date, DCRB changed its name to “Hyzon Motors Inc.” and Legacy Hyzon changed its name to “Hyzon Motors USA Inc.”

The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP, with no goodwill or other intangible assets recorded and the net assets of Legacy Hyzon consolidated with DCRB at historical cost. Under this method of accounting, DCRB is treated as the “acquired” company for financial reporting purposes.

Accordingly, the equity structure has been retrospectively adjusted in all comparative periods up to the Closing Date, to reflect the number of shares of the Company's common stock, $0.0001 par value per share issued to Legacy Hyzon's stockholders in connection with the reverse recapitalization. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Hyzon common stock prior to the Business Combination have been retroactively restated as shares reflecting an exchange ratio of 1.772 (the “Exchange Ratio”).

Liquidity

The Company incurred net losses of $35.7 million and $5.7 million for the three and nine months ended September 30, 2022, respectively. The Company generated net income of $33.8 million and $15.7 million for the three and nine months ended September 30, 2021, respectively. Accumulated deficit amounted to $15.7 million and $26.4 million as of September 30, 2022 and December 31, 2021, respectively. Net cash used in operating activities was $116.2 million and $52.2 million for the nine months ended September 30, 2022 and 2021, respectively.

8

On July 16, 2021, the Company received $509.0 million in cash, net of redemption and transaction costs as a result of the Business Combination. As of September 30, 2022, the Company has $70.6 million in unrestricted cash and cash equivalents, $239.6 million in short-term investments and $7.0 million in restricted cash. Restricted cash is pledged as security for letters of credit or other collateral amounts established by the Company for certain lease obligations, corporate credit cards, and other contractual arrangements. The Company’s restricted cash is included within Other assets in the unaudited interim Consolidated Balance Sheets.

As an early stage growth company, the Company expects to continue to incur net losses in the near term. As the Company commenced its internal restructuring effort in 2022, the primary focuses are the advancement of its proprietary fuel cell technology and development and commercialization of single heavy duty commercial vehicle platform in each region by leveraging third party contracted manufacturers. Until the Company can generate sufficient revenue from product sales, retrofit services or lease arrangements to cover operating expenses, working capital and capital expenditures, the Company will need to raise additional capital. The Company expects to fund cash needs through a combination of equity and debt financing, including lease securitization, strategic collaborations, and licensing arrangements. If the Company cannot raise additional funds when needed, our financial condition, business, prospects, and results of operations could be materially adversely affected.

These financial statements have been prepared by management in accordance with U.S. GAAP and this basis assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. These financial statements do not include any adjustments that may result from the outcome of this uncertainty. As of the date of this Quarterly Report on Form 10-Q, management believes that the Company’s existing financial resources will be sufficient to execute its operating priorities for the next 12 months following the issuance date of these unaudited interim financial statements. As of March 31, 2023, unrestricted cash, cash equivalents, and short-term investments were approximately $210 million.

Risks and Uncertainties

The Company is subject to a variety of risks and uncertainties common to early-stage companies with a history of losses and are expected to incur significant expenses and continuing losses for the foreseeable future. The risks and uncertainties include, but not limited to, further development of its technology, marketing and distribution channels, further development of its supply chain and manufacturing, development by competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, and the ability to secure additional capital to fund operations.

Reclassifications

Certain items previously reported in specific financial statement captions have been reclassified to conform to the current presentation in the consolidated financial statements and the accompanying notes.

Material Transactions

Orten Business Combination Cancellation

In June 2022, the Company entered into an agreement with the intention of acquiring 100% of outstanding ownership in Orten Betriebs GmbH and subsidiaries, and Orten Electric Trucks GmbH (collectively “Orten”). Subsequently, in September 2022, the Company terminated the agreement. As a result of the termination, the Company transferred consideration of €8.5 million (approximately $8.4 million in USD) to Orten consisting of €6.1 million (approximately $6.1 million in USD) in cash and €2.4 million (approximately $2.3 million in USD) in vehicle inventory. The amount of consideration transferred is included within Selling, general and administrative expense in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss).

9

Note 2. Summary of Significant Accounting Policies

The Company’s significant accounting policies are described in Note 3. Summary of Significant Accounting Policies, in the Company’s consolidated financial statements included in the Company’s amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021.

Except for the policies noted below, there have been no material changes to the significant accounting policies for the nine months ended September 30, 2022.

Cash Equivalents

The Company’s cash equivalents consist of short-term, highly liquid financial instruments that are readily convertible to cash with original maturities of three months or less. Due to their short-term nature, the amortized cost of the Company’s cash equivalents approximate fair value. As of September 30, 2022, cash equivalents consisted of commercial paper, certificates of deposit and money market funds totaling $40.6 million. The Company did not have any cash equivalents as of December 31, 2021.

Short-term Investments

The Company has short-term investments in marketable debt securities with an original maturity of greater than three months, but less than one year. These securities include certificates of deposit, commercial paper, corporate debt, foreign government bonds, and U.S. Treasury bills. The Company may sell these marketable debt securities prior to their stated maturities depending upon changing liquidity requirements. The Company’s marketable debt securities have been classified and accounted for as available-for-sale (“AFS”) marketable securities in accordance with ASC 326, Financial Instruments - Credit Losses. AFS securities are recorded at fair value as of each balance sheet date, with unrealized gains or losses included in Accumulated other comprehensive income (loss) and as a component of the Consolidated Statements of Operations and Comprehensive Income (Loss). Gains and losses as a result of sales or maturity of securities are reclassified from previously unrealized gains and losses on short-term investments in Accumulated other comprehensive income (loss) to Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Income (Loss).

For an AFS security with an amortized cost that exceeds its fair value, the Company first determines if it intends to sell or will more-likely-than-not be required to sell the security before the expected recovery of its amortized cost. If it intends to sell or will more-likely-than-not be required to sell the security, then the Company recognizes the impairment as a credit loss in the Consolidated Statements of Operations and Comprehensive Income (Loss) by writing down the security’s amortized cost to its fair value. If it does not intend to sell or it is not more-likely-than-not that it will be required to sell the security before the expected recovery of its amortized cost, the Company recognizes the portion of the impairment that is due to a credit loss, if any, in the Consolidated Statements of Operations and Comprehensive Income (Loss) through an allowance. The portion of the impairment that is due to factors other than a credit loss is recognized in Comprehensive income (loss) in the Consolidated Statements of Operations and Comprehensive Income (Loss) as an unrealized loss. Accrued interest receivable is excluded from the estimate of credit losses (see Note 9. Short-term Investments).

10

Note 3. Revenue

The Company recognized negligible revenue and $2.9 million in sales of hydrogen fuel cell systems in the United States, and sales of FCEVs in China, and retrofit services in Europe for the three and nine months ended September 30, 2022, respectively. The Company recognized revenue of $0.1 million for the three and nine months ended September 30, 2021.

In accordance with ASC 606, the Company is required to evaluate customers’ ability and intent to pay substantially all of the consideration to which the Company is entitled in exchange for the vehicles transferred to the customer, i.e., collectability of contracts with customers. The Company’s customers in China are special purpose entities established in response to China’s national hydrogen fuel cell vehicle pilot program. While in the Company’s estimation the customers have strong business plans and management teams, in consideration of the customers’ limited operating history and extended payment terms in their contracts, the Company determined the collectability criterion is not met with respect to contract existence under ASC 606 for either customer, and therefore, an alternative method of revenue recognition has been applied to each arrangement.

The $2.5 million of revenue recognized from sales of FCEVs in China related to the delivery of 62 FCEVS in the nine months ended September 30, 2022. This amount is equal to the remaining consideration received after satisfying local government VAT obligations, as such amounts are non-refundable and the Company has transferred control of the 62 FCEVs to which the consideration relates and has stopped transferring goods or services to the customer. During the three months ended September 30, 2022, the Company delivered 20 additional FCEVs to a different customer, however, no amounts were recognized as revenue as the consideration received was less than the amounts paid to satisfy local government VAT obligations. The Company will continue to monitor the customers and evaluate the collectability criterion as of each reporting period. The total cost of the 62 FCEVs delivered was recorded within Cost of revenue in the Consolidated Statements of Operations and Comprehensive Loss in 2021 since control of such FCEVs was transferred to the customer prior to December 31, 2021. The total cost of $2.9 million related to the additional 20 FCEVs was recorded within Cost of revenue in the Consolidated Statements of Operations and Comprehensive Income (Loss) during the three months ended September 30, 2022 since control of such FCEVs was transferred at the time of delivery.

Contract Balances

Contract liabilities relate to the advance consideration invoiced or received from customers for products and services prior to satisfying a performance obligation or in excess of amounts allocated to a previously satisfied performance obligation.

The current portion of contract liabilities is recorded within Contract liabilities in the Consolidated Balance Sheets and totaled $0.8 million and $10.9 million as of September 30, 2022 and December 31, 2021, respectively. The long-term portion of contract liabilities is recorded within Other liabilities in the Consolidated Balance Sheets and totaled $5.6 million and $1.0 million as of September 30, 2022 and December 31, 2021, respectively. As part of efforts to exit certain customer contracts, the Company refunded $0.1 million in the fourth quarter of 2022.

Remaining Performance Obligations

The transaction price associated with remaining performance obligations for commercial vehicles and other contracts with customers was $15.4 million as of September 30, 2022. The Company expects to recognize approximately 5% of its remaining performance obligations as revenue over the twelve months after September 30, 2022.

Note 4. Inventory     

Inventory consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Raw materials	$	26,434	$	16,099
Work in process	13,391		4,828
Total inventory	$	39,825	$	20,927

The Company writes down inventory for any excess or obsolescence, or when the Company believes that the net realizable value of inventories is less than the carrying value. Inventory write-downs recognized in Cost of revenue were $2.3 million and $3.0 million for the three and nine months ended September 30, 2022, respectively. The Company did not write down any inventory for the three and nine months ended September 30, 2021, respectively.

11

Note 5. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Deposit for fuel cell components (Note 15)	$	6,017	$	5,008
Vehicle inventory deposits	6,638		10,171
Production equipment deposits	242		1,169
Other prepaid expenses	4,673		3,266
Prepaid insurance	4,345		5,079
VAT receivable from government	2,155		2,159
Total prepaid expenses and other current assets	$	24,070	$	26,852

Note 6. Property, Plant, and Equipment, net

Property, plant, and equipment, net consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Land and building	$	2,818	$	2,818
Machinery and equipment	16,197		8,827
Software	2,071		507
Leasehold improvements	1,356		746
Construction in progress	5,081		2,139
Total Property, plant, and equipment	27,523		15,037
Less: Accumulated depreciation and amortization	(2,654)		(691)
Property, plant and equipment, net	$	24,869	$	14,346

Depreciation and amortization expense totaled $0.8 million and $2.1 million for the three and nine months ended September 30, 2022, respectively. Depreciation and amortization expense totaled $0.2 million and $0.5 million for the three and nine months ended September 30, 2021, respectively.

Note 7. Accrued liabilities

Accrued liabilities consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Payroll and payroll related expenses	$	3,904	$	2,250
Accrued professional fees	5,325		2,450
Accrued product warranty costs	903		816
Accrued contract manufacturer costs	1,346		—
Accrued contract termination costs (Note 12)	2,430		—
Accrued Orten cancellation costs (Note 1)	1,617		—
Accrued severance	475		—
Other accrued expenses	2,586		1,254
Accrued liabilities	$	18,586	$	6,770

12

Note 8. Investments in Equity Securities

The Company owns common shares, participation rights, and options to purchase additional common shares in certain private companies. On a non-recurring basis, the carrying value is adjusted for changes resulting from observable price changes in orderly transactions for identical or similar investments in the same issuer or an impairment.

Included in Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the nine months ended September 30, 2022 is a $12.5 million gain related to the equity investment in Raven SR, Inc. (“Raven”). The investment in Raven’s common shares and options were initially accounted for at cost of $2.5 million. In March 2022, there was an observable change in price of Raven’s common shares. The change in observable price of Raven’s common shares also results in a remeasurement of the investment in Raven’s options as of the date that the observable transaction took place. The fair value of the investment in Raven’s common shares was determined based on observable market prices of identical instruments in less active markets and is classified accordingly as Level 2 in the fair value hierarchy. Due to certain anti-dilution rights included in the options held by the Company, the fair value was determined utilizing a Monte-Carlo simulation model. Accordingly, this was determined to be a Level 3 measurement in the fair value hierarchy. The most significant assumptions in the model included the transaction price of the underlying common shares at the transaction date, expected volatility, risk free rate, and certain assumptions around the likelihood, size, and timing of potential future equity raises by Raven. As of March 31, 2022, the period end in which the observable change in price occurred, the Company determined the fair value of the investment in Raven’s common shares and options to be $6.5 million and $8.5 million, respectively.

Additionally, included in Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the nine months ended September 30, 2022 is a $2.4 million impairment loss related to the Company’s investment in Global NRG H2 Limited (“NRG”), a New Zealand corporation, equal to the initial cost basis. In accordance with ASC 321, Investments - Equity Securities (“ASC 321”), the investment in NRG does not have a readily determinable fair value and is measured at cost minus impairment, which requires the Company to evaluate on an ongoing basis whether an investment has been impaired based on qualitative factors. The Company impaired NRG due to the investee’s lack of progress in developing its plans and operating performance. There was no gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended September 30, 2022.

The following table summarizes the total carrying value of held securities, measured as the total initial cost plus cumulative net gain (loss) (in thousands):

	September 30, 2022		December 31, 2021
Total initial cost basis	$	4,948	$	4,948
Adjustments:
Cumulative unrealized gain	12,530		—
Cumulative impairment	(2,448)		—
Carrying amount, end of period	$	15,030	$	4,948

The following table summarizes unrealized gain and impairment recorded in Other income (expense) in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss), which are included as adjustments to the carrying value of equity securities (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Unrealized gain on equity securities	$	—	$	—	$	12,530	$	—
Cumulative impairment	—		—		(2,448)		—
Total unrealized gain and impairment on equity securities	$	—	$	—	$	10,082	$	—

13

Note 9. Short-term Investments

The following table summarizes the Company's short-term investments (in thousands):

	As of September 30, 2022
	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Short-term investments
Certificates of deposit	$	105,097	$	175	$	(87)	$	105,186
Commercial paper	47,197		105		—		47,302
Corporate debt securities	39,780		—		(181)		39,598
Foreign government bonds	3,187		—		—		3,187
U.S. Treasury bills	44,287		95		(7)		44,375
Total short-term investments	$	239,548	$	375	$	(275)	$	239,648

The Company did not have any short-term investments as of December 31, 2021.

Note 10. Income Taxes

For the nine months ended September 30, 2022, the Company recorded a net discrete tax expense of $0.5 million primarily associated with the establishment of a deferred tax liability that is not expected to offset available deferred tax assets. The Company did not record a provision for income taxes for the three months ended September 30, 2022, because the Company generated tax losses. The Company did not record a provision for income taxes for the three and nine months ended September 30, 2021 because the Company generated tax losses.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company assesses all available evidence, both positive and negative, to determine the amount of any required valuation allowance within each taxing jurisdiction. Full valuation allowances have been established for the Company’s operations in all jurisdictions. As of September 30, 2022, and December 31, 2021, the Company had net deferred tax assets of approximately $43.2 million and $23.0 million, respectively, each of which was fully offset by a valuation allowance.

There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its positions. The Company is subject to income tax examinations by taxing authorities in the countries in which it operates since inception.

14

Note 11. Fair Value Measurements

The Company follows the guidance in ASC 820, Fair Value Measurement. For assets and liabilities measured at fair value on a recurring and nonrecurring basis, a three-level hierarchy of measurements based upon observable and unobservable inputs is used to arrive at fair value. The Company uses valuation approaches that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

•Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

•Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

•Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.

As of September 30, 2022, and December 31, 2021, the carrying amount of accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate estimated fair value due to their relatively short maturities.

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands):

	As of September 30, 2022
	Level 1		Level 2		Level 3		Total
Assets:
Cash equivalents:	$	16,330	$	24,283	$	—	$	40,613
Short-term investments:
Certificates of deposit	—		105,186		—		105,186
Commercial paper	—		47,302		—		47,302
Corporate debt securities	—		39,598		—		39,598
Foreign government bonds	—		3,187		—		3,187
U.S. Treasury bill	44,375		—		—		44,375
Liabilities:
Warrant liability – Private Placement Warrants	$	—	$	1,843	$	—	$	1,843
Earnout shares liability	—		—		16,390		16,390

	As of December 31, 2021
	Level 1		Level 2		Level 3		Total
Liabilities:
Warrant liability – Private Placement Warrants	$	—	$	15,228	$	—	$	15,228
Earnout shares liability	—		—		103,761		103,761

Cash Equivalents

The Company’s cash equivalents consist of short-term, highly liquid financial instruments that are readily convertible to cash with original maturities of three months or less. As of September 30, 2022, the Company has $40.6 million invested in commercial paper, certificates of deposit and money market funds. The Company classifies its investments in commercial paper and certificates of deposit as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

Short-term Investments

The Company’s short-term investments consist of high-quality, investment-grade marketable debt securities and are classified as available-for-sale. The Company classifies its investments in certificates of deposit, commercial paper, corporate debt securities, and foreign government bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

Earnout to Common Stockholders

The fair value of the earnout shares was estimated by utilizing a Monte-Carlo simulation model. The inputs into the Monte-Carlo pricing model included significant unobservable inputs. The following table provides quantitative information regarding Level 3 fair value measurement inputs:

	September 30, 2022			December 31, 2021
Stock price	$	1.70		$	6.49
Risk-free interest rate	4.2		%	1.2		%
Volatility	98.0		%	90.0		%
Remaining term (in years)	3.79			4.54

The following table presents the changes in the liabilities for Private Placement Warrants and Earnout for the nine months ended September 30, 2022 (in thousands):

	Private Placement Warrants		Earnout
Balance as of December 31, 2021	$	15,228	$	103,761
Change in estimated fair value	(13,385)		(87,371)
Balance as of September 30, 2022	$	1,843	$	16,390

The Company performs routine procedures such as comparing prices obtained from independent sources to ensure that appropriate fair values are recorded.

15

Note 12. Commitments and Contingencies

Legal Proceedings

The Company is subject to, and may become a party to, a variety of litigation, other claims, suits, indemnity demands, regulatory actions, and government investigations and inquiries in the ordinary course of business. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain. The Company accrues for matters when we believe that losses are probable and can be reasonably estimated. As of September 30, 2022, the Company accrued $2.4 million in Accrued liabilities in the unaudited interim Consolidated Balance Sheets. The Company did not record any accruals as of December 31, 2021.

As the outcome of individual matters is not predictable with assurance, the assessments are based on the Company’s knowledge and information available at the time; thus, the ultimate outcome of any matter could require payment substantially in excess of the amount being accrued and/or disclosed. The Company is party to current legal proceedings as discussed more fully below.

Shareholder Securities and Derivative Litigation

Three related putative securities class action lawsuits were filed between September 30, 2021 and November 15, 2021, in the U.S. District Court for the Western District of New York against the Company, certain of the Company’s current and former officers and directors and certain former officers and directors of DCRB (Kauffmann v. Hyzon Motors Inc., et al. (No. 21- cv-06612-CJS), Brennan v. Hyzon Motors Inc., et al. (No. 21-cv-06636-CJS), and Miller v. Hyzon Motors Inc. et al. (No. 21-cv-06695-CJS)), asserting violations of federal securities laws. The complaints generally allege that the Company and individual defendants made materially false and misleading statements relating to the nature of the Company’s customer contracts, vehicle orders, and sales and earnings projections, based on allegations in a report released on September 28, 2021, by Blue Orca Capital, an investment firm that indicated that it held a short position in the Company’s stock and which has made numerous allegations about the Company. These lawsuits have been consolidated under the caption In re Hyzon Motors Inc. Securities Litigation (Case No. 6:21-cv-06612-CJS-MWP), and on March 21, 2022, the court-appointed lead plaintiff filed a consolidated amended complaint seeking monetary damages. The Company and individual defendants moved to dismiss the consolidated amended complaint on May 20, 2022, and the court-appointed lead plaintiff filed its opposition to the motion on July 19, 2022. The court-appointed lead plaintiff filed an amended complaint on March 21, 2022, and a second amended complaint on September 16, 2022. Briefing regarding the Company and individual defendants’ anticipated motion to dismiss the second amended complaint has been stayed pending a scheduled, non-binding mediation among the parties. There is no assurance that the mediation will proceed as scheduled, or that, if mediation occurs, any or all parties will reach a settlement.

Between December 16, 2021, and January 14, 2022, three related shareholder derivative lawsuits were filed in the U.S. District Court for the Western District of New York (Lee v. Anderson et al. (No. 21-cv-06744-CJS), Révész v. Anderson et al. (No. 22-cv-06012-CJS), and Shorab v. Anderson et al. (No. 22-cv-06023-CJS)). These three lawsuits have been consolidated under the caption In re Hyzon Motors Inc. Derivative Litigation (Case No. 6:21-cv-06744-CJS). On February 2, 2022, a similar shareholder derivative lawsuit was filed in the U.S. District Court for the District of Delaware (Yellets v. Gu et al. (No. 22-cv-00156)). On February 3, 2022, a similar shareholder derivative lawsuit was filed in the Supreme Court of the State of New York, Kings County (Ruddiman v. Anderson et al. (No. 503402/2022)). On February 13, 2023, a similar shareholder derivative lawsuit was filed in the Delaware Court of Chancery (Kelley v. Knight et al. (C.A. No. 2023-0173)). These lawsuits name as defendants the Company’s current and former directors and certain former directors of DCRB, along with the Company as a nominal defendant, and generally allege that the individual defendants breached their fiduciary duties by making or failing to prevent the misrepresentations alleged in the consolidated securities class action, and assert claims for violations of federal securities laws, breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and/or waste of corporate assets. These lawsuits generally seek equitable relief and monetary damages. With the exception of the recently filed action in the Delaware Court of Chancery, each of the shareholder derivative actions has been stayed or the parties have jointly requested that it be stayed pending a decision regarding the anticipated motion to dismiss in the consolidated securities class action.

16

On March 18, 2022, a putative class action complaint, Malork v. Anderson et al. (C.A. No. 2022-0260- KSJM), was filed in the Delaware Court of Chancery against certain officers and directors of DCRB, DCRB’s sponsor, and certain investors in DCRB’s sponsor, alleging that the director defendants and controlling shareholders of DCRB’s sponsor breached their fiduciary duties in connection with the merger between DCRB and Legacy Hyzon. The complaint seeks equitable relief and monetary damages. On May 26, 2022, the defendants in this case moved to dismiss the complaint. On August 2, 2022, the plaintiff filed an amended complaint. Defendants filed a motion to dismiss the amended complaint on August 15, 2022.

Between January 26, 2022 and August 22, 2022, Hyzon received demands for books and records pursuant to Section 220 of the Delaware General Corporation Law from four stockholders who state they are investigating whether to file similar derivative or stockholder lawsuits, among other purposes. On May 31, 2022, one of these four stockholders represented that he had concluded his investigation and did not intend to file a complaint. On November 18, 2022, a second of the four stockholders filed a lawsuit in the Delaware Court of Chancery (Abu Ghazaleh v. Decarbonization Plus Acquisition Sponsor, LLC et al. (C.A. No. 2022-1050)), which was voluntarily dismissed shortly thereafter on December 1, 2022. On February 13, 2023, a third of these four shareholders filed a derivative lawsuit in the Delaware Court of Chancery (Kelley v. Knight et al. (C.A. No. 2023-0173)). The complaint asserts claims for breach of fiduciary duty and generally alleges that the individual defendants breached their fiduciary duties by making or failing to prevent misrepresentations including those alleged in the consolidated securities class action and the report released by Blue Orca Capital. As with the previously filed shareholder derivative lawsuits, the complaint seeks equitable relief and monetary damages.

On April 18, 2023, the Company received a demand for books and records pursuant to Section 220 of the Delaware General Corporation Law from a stockholder seeking to investigate possible breaches of fiduciary duty or other misconduct or wrongdoing by the Company's controlling stockholder, Hymas Pte. Ltd. ("Hymas"), Hyzon's board of directors (the "Board") and/or certain members of Hyzon's senior management team in connection with the Company's entrance into (i) an equity transfer agreement (the "Equity Transfer") with certain entities affiliated with the Company, and (ii) the share buyback agreement with the Hymas (the "Share Buyback" and, together with the Equity Transfer, the "Transactions") as reported by the Company in its Form 8-K filed on December 28, 2022.

The above proceedings are subject to uncertainties inherent in the litigation process. The Company cannot predict the outcome of these matters or estimate the possible loss or range of possible loss, if any at this time.

Government Investigations

On January 12, 2022, the Company received a subpoena from the SEC for production of documents and information, including documents and information related to the allegations made in the September 28, 2021 report issued by Blue Orca Capital. The Company received two additional subpoenas in connection with the SEC’s investigation on August 5, 2022 and August 10, 2022. On October 31, 2022, the U.S. Attorney’s Office for the Southern District of New York (“SDNY”) notified the Company that it is also investigating these matters. The Company is cooperating and will continue to cooperate with these and any other regulatory or governmental investigations or inquiries. The Company cannot predict the ultimate outcome of the SEC and the SDNY investigations or inquiries. It is not possible to accurately predict at this time when matters will be completed, the final outcome as a result of those investigations or inquiries, what if any actions may be taken by the SEC or the SDNY, or the effect that such actions may have on our business, prospects, operating results and financial condition, which could be material.

17

Customer and Supplier Dispute

From time to time, the Company is subject to various commercial disputes or claims with its customers or suppliers. In January 2023, Duurzaam Transport B.V. and H2 Transport B.V., both private limited companies in the Netherlands and customers of the Company’s European subsidiary, Hyzon Motors Europe B.V. (“Hyzon Europe”), filed an attachment with the local Dutch court. The initial attachment claimed that Hyzon Europe was liable for liquidated and consequential damages stemming from Hyzon Europe allegedly not delivering trucks as contracted. The initial attachment placed a lien on the assets of Hyzon Europe. Following the attachments, Duurzaam Transport B.V. and H2 Transport B.V. initiated proceedings on the merits in February 2023. Eventually, the dispute was settled without any party admitting liability, and the Company made a payment of €2.1 million (approximately $2.0 million in USD) in April 2023, which was recorded in Accrued liabilities in the unaudited interim Consolidated Balance Sheets as of September 30, 2022.

Regardless of outcome, such proceedings or claims can have an adverse impact on the Company because of legal defense and settlement costs, the Company’s obligations to indemnify third parties, diversion of resources, and other factors, and there can be no assurances that favorable outcomes will be obtained. Based on the early-stage nature of these cases, the Company cannot predict the outcome of these currently outstanding customer and supplier dispute matters or estimate the possible loss or range of possible loss, if any.

18

Note 13. Stock-based Compensation Plans

The following table summarizes the Company’s stock option and Restricted Stock Unit (“RSU”) activity:

	Stock Options					RSUs
	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual (Years)	Aggregate Intrinsic Value (in 000s)	Number of RSUs	Weighted Average Grant Date Fair Value
Outstanding at December 31, 2021	19,311,140	$	1.29	13.07	100,885	1,852,685	$	6.14
Granted	539,292	$	4.64	—	—	1,260,408	$	3.72
Exercised or released	(38,868)	$	1.13	—	—	(468,778)	$	6.79
Forfeited/Cancelled	(83,284)	$	1.13	—	—	(106,128)	$	5.15
Outstanding at September 30, 2022	19,728,280	$	1.51	12.17	8,054	2,538,187	$	4.86
Vested and expected to vest, September 30, 2022	14,190,780	$	1.21	11.74	8,054	2,538,187	$	4.86
Exercisable and vested at September 30, 2022	12,410,743	$	1.13	12.54	7,091	—

As of September 30, 2022, there was $2.7 million of unrecognized stock-based compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 3.5 years.

RSUs granted under the Company’s equity incentive plans typically vest over a four or five-year period beginning on the date of grant. RSUs will be settled through the issuance of an equivalent number of shares of the Company’s common stock and are equity classified. The fair value of restricted shares is determined based upon the stock price on the date of grant. As of September 30, 2022, unrecognized compensation costs related to unvested RSUs of $11.1 million is expected to be recognized over a remaining weighted average period of 3.09 years.

Earnout to Other Equity Holders

Earnout awards to other equity holders accounted for under ASC 718, Compensation - Stock Compensation (“ASC 718”) were vested at the time of grant, and therefore recognized immediately as compensation expense. Total compensation expense/(benefit) recorded for the three and nine months ended September 30, 2022 related to these earnout awards was $(0.1) million and $0.8 million, respectively. Total compensation expense recorded for the three and nine months ended September 30, 2021 related to these earnout awards was $14.0 million. Certain earnout awards to other equity holders contained performance and market-based vesting conditions, and as the performance conditions are not deemed probable at September 30, 2022, no compensation expense has been recorded related to these awards.

19

Note 14. Stockholders' Equity

Common Stock

The Company is authorized to issue 400,000,000 shares of common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At September 30, 2022 and December 31, 2021, there were 248,153,362 and 247,758,412 shares of Class A common stock issued and outstanding, respectively.

Warrants

At September 30, 2022, there were 11,013,665 Public Warrants and 8,014,500 Private Placement Warrants, for a total of 19,028,165 warrants outstanding. At December 31, 2021, there were 11,286,242 Public Warrants and 8,014,500 Private Placement Warrants, for a total of 19,300,742 warrants outstanding. At September 30, 2022, and December 31, 2021, there were 170,048 and 275,048 Ardour Warrants outstanding, respectively.

Equity Repurchase Program

On November 17, 2021, the Company’s board of directors authorized the repurchase of up to $5.0 million of its outstanding common stock and/or Public Warrants. The timing and amount of any share repurchases under the Company’s share repurchase authorization will be determined by management based on market conditions and other considerations. Such repurchases may be executed in the open market. As of December 31, 2021, the Company had repurchased 256,977 public warrants for $0.5 million. In the nine months ended September 30, 2022, the Company repurchased an additional 15,600 public warrants for $31 thousand. The Company repurchased a total of 272,577 public warrants and suspended the share repurchase program as of January 5, 2022.

20

Note 15. Related Party Transactions

Horizon IP Agreement

In January 2021, the Company entered into an intellectual property agreement (the “Horizon IP Agreement”) with Jiangsu Qingneng New Energy Technologies Co., Ltd. and Shanghai Qingneng Horizon New Energy Ltd. (together, “JS Horizon”) both of which are subsidiaries of the Company’s ultimate parent, Horizon. In September 2021, Jiangsu Horizon Powertrain Technologies Co. Ltd. (“JS Powertrain”) was an added party to the agreement. Pursuant to the agreement the parties convey to each other certain rights in intellectual property relating to Hyzon’s core fuel cell and mobility product technologies, under which Hyzon was to pay JS Horizon and JS Powertrain a total fixed payment of $10.0 million. The full $10.0 million has been paid, $6.9 million was paid in 2021 and the remaining $3.1 million was paid in February 2022.

Related Party Payables and Receivables

Horizon Fuel Cell Technologies and Related Subsidiaries

The Company made deposit payments to Horizon and its subsidiaries to secure certain fuel cell components. As of September 30, 2022, the remaining balance is $6.0 million and included within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance Sheets.

Certain employees of Horizon and its subsidiaries provide research and development, staff training, and administrative services to the Company. Based on an analysis of the compensation costs incurred by Horizon and an estimate of the proportion of effort spent by such employees on each entity, an allocation of approximately $0.4 million and $1.2 million was recorded in the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the three months ended September 30, 2022, and 2021, respectively. An allocation of approximately $0.9 million and $1.8 million was recorded in the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the nine months ended September 30, 2022, and 2021, respectively.

The related party payable to Horizon and its subsidiaries is $0.1 million and $3.7 million as of September 30, 2022 and December 31, 2021, respectively.

Holthausen and Affiliates

The Company entered into a joint venture agreement in October 2020 to create Hyzon Europe with Holthausen Clean Technology Investments B.V. (“Holthausen”). As Hyzon Europe builds out its production facilities, it relies on Holthausen and its affiliates for certain production resources that result in related party transactions. In addition, both companies rely on certain suppliers, including Horizon.

The Company currently owns 50.5% of the equity interests of Hyzon Europe. On December 31, 2021, Hyzon executed a non-binding Letter of Intent (“LOI”) with Holthausen to increase its stake to 75% in Hyzon Europe. Concurrent with the signing of this LOI, a €1 million refundable deposit was paid to Holthausen, approximately $1.1 million in U.S. dollars (“USD”). This deposit is recorded within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance Sheets.

Subsequently, in December 2022, the Company acquired the remaining 49.5% of the equity interests of Hyzon Europe from Holthausen. The Company now holds 100% ownership in Hyzon Europe. The Company paid €3.5 million (approximately $3.7 million in USD) in addition to €1.0 million (approximately $1.1 million in USD) paid in December 2021. As part of this transaction, the Company also transferred various inventory items to, and settled open related party balances with, Holthausen. In addition, the Company reassigned all of the assumed retrofit service contracts, including after-sales obligations, back to Holthausen Clean Technology B.V.

For the three and nine months ended September 30, 2022, the Company paid $0.1 million and $0.4 million, respectively, to Carl Holthausen and Max Holthausen as managing directors of Hyzon Europe. For the three and nine months ended September 30, 2021, the Company paid $0.1 million and $0.3 million, respectively.

As of September 30, 2022, the related party payable to Holthausen is $0.3 million. As of December 31, 2021, the related party receivable from Holthausen is $0.3 million.

Jiushuang Joint Ventures

As described in Note 3. Revenue, the Company delivered 20 FCEVs to Jiushuang (Shanghai) New Energy Technology Co., Ltd. during the three months ended September 30, 2022. Jiushuang (Shanghai) New Energy Technology Co., Ltd. is a parent of both Jiushuang Tiancheng Motors Service Ltd. (“JSTC”) and Jiushuang Suda Logistics Ltd. (“JSSD”), which the Company partnered with to form the Jiushuang joint ventures.

21

Note 16. Income (Loss) per share

Basic net income (loss) per share is computed by dividing net income attributable to shareholders of Hyzon by the weighted-average number of common shares outstanding during the reporting period. Diluted net income per share is computed similarly to basic net income per share, except that it includes the potential dilution that could occur if dilutive securities were exercised.

The following table presents the information used in the calculation of the Company’s basic and diluted net income (loss) per share attributable to Hyzon common stockholders (in thousands, except per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income (loss) attributable to Hyzon	$	(24,795)	$	34,621	$	10,681	$	17,053
Weighted average shares outstanding:
Basic	248,164		234,091		248,054		189,101
Effect of dilutive securities	—		12,389		9,774		11,883
Diluted	248,164		246,480		257,828		200,984
Net income (loss) per share attributable to Hyzon:
Basic	$	(0.10)	$	0.15	$	0.04	$	0.09
Diluted	$	(0.10)	$	0.14	$	0.04	$	0.08

The weighted average number of shares outstanding prior to Business Combination were converted at the Exchange Ratio.

Potentially dilutive shares are excluded from the computation of diluted net income (loss) per share when their effect was antidilutive. The potential dilutive securities are summarized as follows (in thousands):

	Three Months Ended September 30,		Nine Months Ended September 30,
	2022	2021	2022	2021
Restricted stock units	2,538	426	937	426
Stock options with service conditions	12,419	—	539	—
Stock options for former CTO	1,772	—	—	—
Stock options with market and performance conditions	5,538	5,538	5,538	5,538
Private placement warrants	8,015	8,015	8,015	8,015
Public warrants	11,014	11,286	11,014	11,286
Earnout shares	23,250	23,250	23,250	23,250
Hongyun warrants	31	—	31	—
Ardour warrants	170	326	—	326

22

Note 17. Subsequent Events

Raven SR S1 LLC

In December 2022, the Company entered into an agreement with Chevron New Energies and Raven, to invest in Raven SR S1 LLC. Raven SR S1 LLC intends to develop, construct, operate and maintain a solid waste-to hydrogen generation production facility located in Richmond, California. The Company invested $8.5 million at closing, and the remaining $1.5 million will be paid in 2023 for an approximate 20% ownership in Raven SR S1 LLC. The Company accounted for the agreement as an equity method investment with a cost basis determined by the funding date capital contribution. The subsequent payment will add to the overall cost basis of the investment when paid.

Divestiture of Hyzon Guangdong

In December 2022, the Company sold all of its equity interest in Hyzon Motors Technology (Guangdong) Co., Ltd. (“Hyzon Guangdong”) to Hymas for approximately $3.1 million in cash, subject to certain adjustments. As a common control transaction, the difference of $0.5 million between the consideration received and the book value is expected to be recognized in the Company’s additional paid-in-capital during the three months ended December 31, 2022. Subsequent to the divestiture, Hyzon Guangdong changed its name to Guangdong Qingyun Technology Co. Ltd. (“Guangdong Qingyun”).

Additionally, together with the execution of the Hyzon Guangdong divestiture, the Company entered into a share buyback agreement and repurchased approximately 3.8 million shares of common stock from Hymas in exchange for approximately $6.4 million in cash.

In April 2023, Guangdong Qingyun paid $3.3 million to the Company to settle intercompany balances and Hymas paid the Company $3.1 million related to the Hyzon Guangdong divestiture.

Nasdaq Deficiency Notice

In February 2023, the Company received a Staff Determination from the Listing Qualifications Staff of Nasdaq notifying the Company that unless the Company requests an appeal, trading of the Company's Class A common stock and warrants will be suspended from The Nasdaq Capital Market at the opening of business on February 14, 2023, and a Form 25-NSE will be filed with the SEC. On February 10, 2023, the Hearings Panel granted the Company a 15 calendar day stay of delisting, and will notify the Company within this 15 calendar day period whether the Company’s request for a stay pending the hearing will be granted. The date for the delisting hearing was March 16, 2023. At the hearing, the Company presented its plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) and requested the continued listing of its securities on The Nasdaq Capital Market pending such compliance. In March 2023, the Company received a letter from the Hearings Panel indicating that the Hearings Panel granted the Company’s request for continued listing until May 15, 2023, in order to allow the Company to regain compliance with the periodic filing rule.

On April 6, 2023, the Company received an additional Staff Determination (the “Additional Staff Determination”) from the Staff notifying the Company that, because the Staff did not receive the Company’s Form 10-K for the year ended December 31, 2022, the Company does not comply with Nasdaq’s Listing Rules for continued listing, thus constituting an additional basis for delisting the Company’s securities from The Nasdaq Capital Market. The Additional Staff Determination further notified the Company that the Hearings Panel will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market, and that the Company should present its views with respect to this additional deficiency to the Hearings Panel in writing no later than April 13, 2023. On April 13, 2023, the Company filed its response to the Additional Staff Determination.

Delaware Court of Chancery Section 205

On February 13, 2023, the Company filed a petition under the caption In re Hyzon Motors Inc., C.A. No. 2023-0177-LWW (Del. Ch) in the Delaware Court of Chancery pursuant to Section 205 of the Delaware General Corporation Law (“DGCL”), which permits the Court of Chancery, in its discretion, to validate potentially defective corporate acts due to developments regarding potential interpretations of the DGCL stemming from the Court’s recent decision in Garfield v. Boxed, Inc., 2022 WL 17959766 (Del. Ch. Dec. 27, 2022). On March 6, 2023, the Court of Chancery granted our petition, holding that any defects that may have existed with respect to the conduct of the Special Meeting of Shareholders held on July 15, 2021 to approve the increase in the Company’s authorized share capital were ratified as of the meeting.

The Company continues to believe that, notwithstanding the relief the Delaware Court of Chancery granted to the Company under Section 205, at the time of DCRB Shareholder Meeting on July 16, 2021, the increase in the Company’s authorized share capital was validly approved by DCRB’s shareholders under Delaware law.

23

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis provide information that management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. This discussion is intended to supplement, and should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2021 Annual Report filed on Form 10-K/A. Unless the context otherwise requires, all references in this section to “Hyzon,” “we,” “us,” and “our” are intended to mean the business and operations of Hyzon Motors Inc. and its consolidated subsidiaries following the consummation of the Business Combination and to Legacy Hyzon and its consolidated subsidiaries prior to the Business Combination.

Overview

Headquartered in Honeoye Falls, New York, with major operations in the United States, the Netherlands, and Australia. Hyzon provides decarbonized solutions primarily for commercial vehicles market and hydrogen supply infrastructure.

Vehicles and Vehicle Platforms

Our commercial vehicle business is focused primarily on assembling and supplying hydrogen-powered fuel cell electric vehicles (“FCEVs”). Our new strategy takes a focused approach by designing and developing one vehicle platform at each region to conform with regional regulations and customer preferences. Our strategy to manufacture fuel cells in-house and work with 3rd party vehicle assemblers will enable us to maintain an asset-light business model, lower production costs and ultimately lower Total Cost of Ownership (“TCO”) for the customer, which is a prerequisite for scaling deployments of heavy and medium duty trucks with customers.

On-road, our potential customers include shipping and logistics companies and retail customers with large distribution networks, such as grocery retailers, food and beverage companies, waste management companies, and municipality and government agencies around the world. Off-road, our potential customers include mining, material handling and port equipment manufacturers and operators. Initial strategic customer groups often employ a ‘back-to-base’ model where their vehicles return to a central base or depot between operations, thereby allowing operators to have fueling independence as the necessary hydrogen can be produced locally at or proximate to the central base and dispensed at optimally-configured hydrogen refueling stations. Hyzon may expand its range of products and hydrogen solutions as the transportation sector increasingly adopts hydrogen propulsion and investments are made in hydrogen production and related infrastructure in accordance with our expectations.

In addition, we plan to expand our integration activities across rail, aviation, mobile power and other applications in the future. We expect the opportunities in these sectors to continue to expand with the rapid technological advances in hydrogen fuel cells and the increasing investments in hydrogen production, storage and refueling infrastructure around the world.

Fuel and Infrastructure

Our hydrogen supply infrastructure business is focused on building and fostering a clean hydrogen supply ecosystem with leading partners from feedstock through hydrogen production, dispensing and financing. We collaborate with strategic partners on development, construction, operation, and ownership of hydrogen production facilities and refueling stations in each major region of our operations, which we intend to complement our back-to-base model and near-term fleet deployment opportunities.

24

Key Trends and Uncertainties

We believe that our performance and future success depend on several factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in the section entitled “Risk Factors” included in our amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021.

Commercial Launch of Hyzon-branded commercial vehicles and other hydrogen solutions

We reported negligible revenue and $2.9 million of revenue from the sale of hydrogen fuel cell systems in the United States, FCEVs in China, and retrofit services in Europe for the three and nine months ended September 30, 2022, respectively. However, our business model has yet to be proven. Prior to full commercialization of our commercial vehicle business at scale, we must complete the construction of required manufacturing facilities and achieve research and development milestones. We must establish and operate facilities capable of producing our hydrogen fuel cell systems and leverage 3rd party vehicle manufacturers to assemble our hydrogen-powered commercial vehicles in appropriate volumes and at competitive costs.

Until we can generate sufficient additional revenue from our commercial vehicle business, we expect to finance our operations through equity and/or debt financing. The amount and timing of our future funding requirements will depend on many factors, including the pace and results of our development efforts. We expect that any delays in the successful completion of our manufacturing facilities, availability of critical parts, and/or validation and testing will impact our ability to generate revenue.

Hydrogen Production & Supply Infrastructure

We continue to develop an end-to-end hydrogen ecosystem delivery model, with a partner-driven approach to design, build, own and operate hydrogen production hubs and downstream dispensing infrastructure expected to provide zero-to-negative carbon intensity hydrogen at below diesel-parity cost structures supporting Hyzon vehicle fleet deployments. We intend to continue forming additional partnerships across the full hydrogen feedstock, production and dispensing value chain in each major region in which we operate, that will be designed to ensure that the hydrogen fuel required is available at the cost and carbon intensity requirements to drive fleet conversions to Hyzon hydrogen FCEVs. Because we have a partner-driven approach, we are naturally reliant upon our partners’ performance in fulfilling the obligations that we depend on for delivery of each segment of that value chain. Additionally, consistent with other construction projects, there are risks related to realized construction cost and schedule that can impact final cost to produce and deliver hydrogen and timing of that delivery, along with the availability of feedstock near our vehicle fleet deployments. We intend to manage these risks by partnering with high quality and high performing partners with a track record of timely delivery and instituting commercial agreements to drive down construction cost and achieve on-time scheduled performance.

Continued Investment in Innovation

We believe that we are the industry-leading hydrogen technology company with the most efficient and reliable fuel cell powertrain technologies and an unmatched product and service offering. Our financial performance will be significantly dependent on our ability to maintain this leading position. We expect to incur substantial and increasing research and development expenses as a result. We dedicate significant resources towards research and development and invest heavily in recruiting talent, especially for vehicle design, vehicle software, fuel cell system, and electric powertrain. We will continue to recruit and retain talented personnel to grow our strength in our core technologies. We expect to incur additional stock-based compensation expenses as we support our growth and status as a publicly traded company. We expect our strategic focus on innovation will further solidify our leadership position.

Customer Demand

We are continually seeking to expand our customer base; however, we depend on a few major customers and we expect this will continue for the next several years. These customers will mostly employ a back-to-base model in the early adoption phase of FCEVs. Vehicles will return to a central “base” between operations, allowing them to refuel onsite and/or nearby, where hydrogen can be produced locally at or proximate to the central base. While we focus on back-to-base or regional customers, we expect to expand our target customer focus to include longer-haul truck and bus segments, additional vehicle classes, mobile power, and incremental mobility applications (e.g., rail, aviation) for customers around the world.

25

Supplier Relationships

We depend on third parties, including our majority beneficial shareholder and parent company Horizon for supply of key inputs and components for our products, such as fuel cells and automotive parts. We intend to negotiate potential relationships with industry-leading OEMs to supply chassis for our Hyzon-branded vehicles but do not yet have any binding agreements and there is no guarantee that definitive agreements will be reached. Even if we reach such agreements, such suppliers, including Horizon, may be unable to deliver the inputs and components necessary for us to produce our hydrogen-powered commercial vehicles or hydrogen fuel cell systems at prices, volumes, and specifications acceptable to us. If we are unable to source required inputs and other components from third parties on acceptable terms, it could have a material adverse effect on our business and results of operations.

The automotive industry continues to face many supply chain disruptions. We are experiencing increases in both the cost of and time to receive raw materials, such as semiconductors or chassis. Any such increase or supply interruptions could materially negatively impact our business, prospects, financial condition, and operating results. Many of the parts for our products are sourced from suppliers in China, and the manufacturing situation in China remains uncertain.

Market Trends and Competition

The last ten years have seen the rapid development of alternative energy solutions in the transportation space. We believe this growth will continue to accelerate as increased product offerings, technological developments, reduced costs, additional supporting infrastructure, and increased global focus on climate goals drive broader adoption.

We believe that commercial vehicle operators, one of our initial target markets, will be driven towards hydrogen-powered commercial vehicles predominantly by the need to decarbonize activities, but also by the potential for lower total cost of ownership in comparison to the cost of ownership associated with traditional gasoline and diesel internal combustion engines. Our fuel cell technology can be deployed across a broad range of mobility applications, including on-road, off-road, rail, maritime and aviation.

The competitive landscape for our commercial vehicles ranges from vehicles relying on legacy internal combustion engines, to extended range electric and battery electric engines, to other hydrogen fuel cell and alternative low-to-no carbon emission propulsion vehicles. Competitors include well established vehicle companies already deploying vehicles with internal fuel cell technology and other heavy vehicle companies that have announced their plans to offer fuel cell trucks in the future. We also face competition from other fuel cell manufacturers. We believe that our company is well positioned to capitalize on growth in demand for alternative low-to-no carbon emission propulsion vehicles due to the numerous benefits of hydrogen power, including hydrogen’s abundance and ability to be produced locally and the generally faster refueling times for hydrogen-powered commercial vehicles, as compared to electricity-powered vehicles. However, in order to successfully execute on our business plan, we must continue to innovate and convert successful research and development efforts into differentiated products, including new commercial vehicle models.

Our current and potential competitors have greater financial, technical, manufacturing, marketing and other resources. Our competitors may be able to deploy greater resources to the design, development, manufacturing, distribution, promotion, sales, marketing, and support of their internal combustion, alternative fuel and electric truck programs.

Regulatory Landscape

We operate in a highly regulated industry. The failure to comply with laws or regulations, including but limited to rules and regulations covering vehicle safety, emissions, dealerships, and distributors, could subject us to significant regulatory risk and changing laws and regulations and changing enforcement policies and priorities could adversely affect our business, prospects, financial condition and operating results. We may be also required to obtain and comply with the terms and conditions of multiple environmental permits, many of which are difficult and costly to obtain and could be subject to legal challenges. We depend on global customers and suppliers, and adverse changes in governmental policy or trade regimes could significantly impact the competitiveness of our products. Changes to applicable tax laws and regulations or exposure to additional income tax liabilities could affect our business and future profitability. See the section entitled “Government Regulations” in our amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021.

26

Results of Operations

The following table sets forth our historical operating results for the periods indicated (in thousands):

	Three Months Ended September 30,								Nine Months Ended September 30,
	2022		2021		$ Change		% Change		2022		2021		$ Change		% Change
Revenue	$	5	$	89	$	(84)	(94)	%	$	2,939	$	89	$	2,850	3202	%
Operating expense:
Cost of revenue	8,203		204		7,999		3921	%	10,226		204		10,022		4913	%
Research and development	9,241		3,982		5,259		132	%	26,660		8,081		18,579		230	%
Selling, general, and administrative	36,103		42,661		(6,558)		(15)	%	75,920		51,607		24,313		47	%
Total operating expenses	53,547		46,847		6,700		14	%	112,806		59,892		52,914		88	%
Loss from operations	(53,542)		(46,758)		(6,784)		15	%	(109,867)		(59,803)		(50,064)		84	%
Other income (expense):
Change in fair value of private placement warrant liability	3,447		7,614		(4,167)		(55)	%	13,385		7,614		5,771		76	%
Change in fair value of earnout liability	18,034		73,359		(55,325)		(75)	%	87,371		73,359		14,012		19	%
Gain (loss) on equity securities	—		—		—		N/M		10,082		—		10,082		N/M
Foreign currency exchange loss and other income	(3,871)		(116)		(3,755)		3237	%	(6,475)		(175)		(6,300)		3600	%
Interest income (expense), net	279		(254)		533		(210)	%	350		(5,249)		5,599		(107)	%
Total other income (expense)	17,889		80,603		(62,714)		(78)	%	104,713		75,549		29,164		39	%
Net income (loss) before income taxes	(35,653)		33,845		(69,498)		(205)	%	(5,154)		15,746		(20,900)		(133)	%
Income tax expense	—		—		—		N/M		526		—		526		N/M
Net income (loss)	$	(35,653)	$	33,845	$	(69,498)	(205)	%	$	(5,680)	$	15,746	$	(21,426)	(136)	%
Less: Net loss attributable to noncontrolling interest	(10,858)		(776)		(10,082)		1299	%	(16,361)		(1,307)		(15,054)		1152	%
Net income (loss) attributable to Hyzon	$	(24,795)	$	34,621	$	(59,416)	(172)	%	$	10,681	$	17,053	$	(6,372)	(37)	%

27

Three Months Ended September 30, 2022 and 2021

Revenue. We generated negligible revenue for the three months ended September 30, 2022 and $0.1 million of revenue from retrofit services performed by Hyzon Europe for the three months ended September 30, 2021.

Operating Expenses. Operating expenses for the three months ended September 30, 2022 were $53.5 million compared to $46.8 million for the three months ended September 30, 2021. Operating expenses consist of cost of revenue, research and development expenses and selling, general and administrative expenses.

Cost of Revenue. Cost of revenue includes direct materials, labor costs, allocated overhead costs related to the manufacturing and retrofitting of hydrogen FCEVs, fuel cell systems, estimated warranty costs, and inventory write-downs. Cost of revenue for the three months ended September 30, 2022 was $8.2 million and was $0.2 million for the three months ended September 30, 2021. Cost of revenue for the three months ended September 30, 2022 was primarily related to cost provisions accrued for customer contract activities in Europe, the write-down of inventory in Europe and cost of 20 FCEVs delivered to Jiushuang.

Research and Development Expenses. Research and development expenses represent costs incurred to support activities that advance the development of current and next generation hydrogen powered fuel cell systems, the design and development of electric powertrain, and the integration of those systems into various mobility applications. Our research and development expenses consist primarily of employee-related personnel expenses, prototype materials and tooling, design expenses, consulting and contractor costs and an allocated portion of overhead costs.

Research and development expenses were $9.2 million and $4.0 million for the three months ended September 30, 2022 and 2021, respectively. The increase was primarily due to $1.9 million in higher personnel costs, which were incurred in order to enhance our research and development expertise in vehicle design, vehicle software, fuel cell system, and electric powertrain. The remaining increase of $3.3 million is for materials used in research and development to further develop current and next generation hydrogen powered fuel cell systems, to design and develop an electric powertrain, and to integrate those systems into various mobility applications. We expect research and development expenses to continue to increase significantly going forward as we build out our research facilities and organization.

Selling, General, and Administrative Expenses. Selling expenses consist primarily of employee-related costs for individuals working in our sales and marketing departments, third-party commissions, and related outreach activities. General and administrative expenses consist primarily of personnel-related expenses associated with our executive, finance, legal, information technology and human resources functions, as well as professional fees for legal, audit, accounting and other consulting services, and an allocated portion of overhead costs.

Selling, general, and administrative expenses were $36.1 million and $42.7 million for the three months ended September 30, 2022 and 2021, respectively. The decrease was primarily due to $26.8 million in lower stock compensation expense. The decrease is offset by an increase of $8.3 million in higher legal, accounting and consulting fees incurred in connection with regulatory and legal matters including litigation and SEC investigation, $1.8 million in higher salary and related expenses, and $2.3 million in IT, rent, travel and other office related expenses to support business growth. In addition, we incurred $8.4 million related to the cancellation of the Orten acquisition in Europe.

Change in Fair Value. Change in fair value represents non-cash gains or losses in estimated fair values of the private placement warrant liability, earnout liability, and investments in equity securities. Private placement warrant and earnout liabilities are remeasured at each balance sheet date. Equity securities are remeasured when there is an observable price adjustment in an orderly transaction for an identical or similar investment in the same investee entity. Changes in estimated fair values of private placement warrant liability and earnout liability for the three months ended September 30, 2022, were $3.4 million and $18.0 million, respectively. Changes in estimated fair values of private placement warrant liability and earnout liability for the three months ended September 30, 2021 were $7.6 million and $73.4 million, respectively.

Foreign Currency Exchange Loss and Other Expense. Foreign currency exchange loss represents exchange rate gains and losses related to all transactions denominated in a currency other than our or our subsidiary’s functional currencies. Foreign currency exchange loss was $3.9 million for the three months ended September 30, 2022, compared to $0.1 million for the three months ended September 30, 2021, as there were few transactions in foreign currencies in the prior period.

28

Interest Income (Expense), net. Interest income was $0.3 million for the three months ended September 30, 2022, compared to interest expense of $0.3 million for the three months ended September 30, 2021. Interest expense in the three months ended September 30, 2021, relates primarily to the convertible debt issued in February 2021 and is comprised primarily from changes in the fair value of an embedded derivative associated with the automatic conversion provision of the convertible notes. Upon close of the Business Combination in July 2021, the convertible debt and accrued interest converted into shares of common stock of the Company. There was no debt outstanding during the three months ended September 30, 2022.

Income Tax Expense. We had no income tax expense for the three months ended September 30, 2022 and 2021.

Net Loss Attributable to Noncontrolling Interests. Net loss attributable to noncontrolling interests represents results attributable to third parties in our operating subsidiaries. Net loss is generally allocated based on such ownership interests held by third parties with respect to each of these entities.

Net loss attributable to noncontrolling interests was $10.9 million and $0.8 million for the three months ended September 30, 2022 and 2021, respectively. The change in the comparative periods is the result of increased activities in our Netherlands joint venture and the creation of a joint venture in Foshan, China in October 2021.

Nine Months Ended September 30, 2022 and 2021

Revenue. Revenue for the nine months ended September 30, 2022 was $2.9 million, and represents sales of fuel cell systems in the United States, FCEVs in China and retrofit services in Europe. Revenue for the nine months ended September 30, 2021 was $0.1 million from retrofit services performed by Hyzon Europe.

Operating Expenses. Operating expenses for the nine months ended September 30, 2022 were $112.8 million compared to $59.9 million for the nine months ended September 30, 2021. Operating expenses consist of cost of revenue, research and development expenses and selling, general and administrative expenses.

Cost of Revenue. Cost of revenue includes direct materials, labor costs, allocated overhead costs related to the manufacturing and retrofitting of hydrogen FCEVs, fuel cell systems, estimated warranty costs, and inventory write-downs. Cost of revenue for the nine months ended September 30, 2022 was $10.2 million and was $0.2 million for the nine months ended September 30, 2021. Cost of revenue for the nine months ended September 30, 2022 was primarily related to cost provisions accrued for customer contract activities in Europe, the write-down of inventory in Europe and cost of 20 FCEVs delivered to Jiushuang.

Research and Development Expenses. Research and development expenses represent costs incurred to support activities that advance the development of current and next generation hydrogen powered fuel cell systems, the design and development of electric powertrain, and the integration of those systems into various mobility applications. Our research and development expenses consist primarily of employee-related personnel expenses, prototype materials and tooling, design expenses, consulting and contractor costs and an allocated portion of overhead costs.

Research and development expenses were $26.7 million and $8.1 million in the nine months ended September 30, 2022 and 2021, respectively. The increase was primarily due to $9.1 million in higher personnel costs, which were incurred in order to enhance our research and development expertise in vehicle design, vehicle software, fuel cell system, and electric powertrain. The remaining increase of $9.5 million is for materials used in research and development to further develop current and next generation hydrogen powered fuel cell systems, to design and develop an electric powertrain, and to integrate those systems into various mobility applications. We expect research and development expenses to continue to increase significantly going forward as we build out our research facilities and organization.

Selling, General, and Administrative Expenses. Selling expenses consist primarily of employee-related costs for individuals working in our sales and marketing departments, third-party commissions, and related outreach activities. General and administrative expenses consist primarily of personnel-related expenses associated with our executive, finance, legal, information technology and human resources functions, as well as professional fees for legal, audit, accounting and other consulting services, and an allocated portion of overhead costs.

29

Selling, general, and administrative expenses were $75.9 million and $51.6 million in the nine months ended September 30, 2022 and 2021, respectively. The increase was primarily due to $16.5 million in higher legal, accounting and consulting fees incurred in connection with regulatory and legal matters including litigation and SEC investigation, $9.4 million in higher salary and related expenses, $5.5 million in higher insurance expense and $7.7 million in IT, rent, travel and other office related expenses to support business growth. In addition, we incurred $8.4 million related to the cancellation of the Orten acquisition in Europe. The increase is offset by $24.6 million in lower stock compensation expense. We incurred greater selling, general, and administrative expense for the nine months ended September 30, 2022 as the Company continues to build out its corporate infrastructure, including accounting, audit, legal, regulatory and tax-related services. The increase also resulted from higher director and officer insurance costs, investor and public relations costs.

Change in Fair Value. Change in fair value represents non-cash gains or losses in estimated fair values of the private placement warrant liability, earnout liability, and investments in equity securities. Private placement warrant and earnout liabilities are remeasured at each balance sheet date. Equity securities are remeasured when there is an observable price adjustment in an orderly transaction for an identical or similar investment in the same investee entity. Changes in estimated fair values of private placement warrant liability, earnout liability, and investments in equity securities for the nine months ended September 30, 2022, were $13.4 million, $87.4 million, and $10.1 million, respectively. The $10.1 million increase in the estimated fair value in investments in equity securities represents a $12.5 million gain related to our equity investment in Raven, offset by a $2.4 million impairment of our equity investment in NRG. Change in estimated fair value of private placement warrant and earnout liabilities for the nine months ended September 30, 2021 were $7.6 million and $73.4 million, respectively.

Foreign Currency Exchange Loss and Other Expense. Foreign currency exchange loss represents exchange rate gains and losses related to all transactions denominated in a currency other than our or our subsidiary’s functional currencies. Foreign currency exchange loss was $6.5 million for the nine months ended September 30, 2022, compared to $0.2 million in the nine months ended September 30, 2021, as there were few transactions in foreign currencies in the prior period.

Interest Income (Expense), net. Interest income was $0.4 million in the nine months ended September 30, 2022, compared to interest expense of $5.2 million in the nine months ended September 30, 2021. Interest expense in the nine months ended September 30, 2021, relates primarily to the convertible debt issued in February 2021 and is comprised primarily from changes in the fair value of an embedded derivative associated with the automatic conversion provision of the convertible notes. Upon close of the Business Combination in July 2021, the convertible debt and accrued interest converted into shares of common stock of the Company. There was no debt outstanding for the nine months ended September 30, 2022.

Income Tax Expense. For the nine months ended September 30, 2022, the Company recorded a net discrete tax expense of $0.5 million primarily associated with the establishment of a deferred tax liability that is not expected to offset available deferred tax assets. The Company has cumulative net operating losses at the federal and state level and maintains a full valuation allowance against its net deferred tax assets. We had no income tax expense for the nine months ended September 30, 2021.

Net Loss Attributable to Noncontrolling Interests. Net loss attributable to noncontrolling interests represents results attributable to third parties in our operating subsidiaries. Net loss is generally allocated based on such ownership interests held by third parties with respect to each of these entities.

Net loss attributable to noncontrolling interests was $16.4 million and $1.3 million for the nine months ended September 30, 2022 and 2021, respectively. The change in the comparative periods is the result of increased activities in our Netherlands joint venture and the creation of a joint venture in Foshan, China in October 2021.

30

Non-GAAP Financial Measures

In addition to our results determined in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), we believe the following non-GAAP measures are useful in evaluating our operational performance. We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors in assessing our operating performance.

EBITDA and Adjusted EBITDA

“EBITDA” is defined as net income (loss) before interest income or expense, income tax expense or benefit, and depreciation and amortization. “Adjusted EBITDA” is defined as EBITDA adjusted for stock-based compensation expense, change in fair value of private placement warrant liability, change in fair value of earnout liability, gain (loss) on equity securities and other special items determined by management, if applicable. EBITDA and Adjusted EBITDA are intended as supplemental measures of our performance that are neither required by, nor presented in accordance with, U.S. GAAP. We believe that the use of EBITDA and Adjusted EBITDA provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with those of comparable companies, which may present similar non-GAAP financial measures to investors. However, you should be aware that when evaluating EBITDA and Adjusted EBITDA we may incur future expenses similar to those excluded when calculating these measures. In addition, our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Our computation of EBITDA and Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies, because all companies may not calculate in the same fashion.

Because of these limitations, EBITDA and Adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP. We compensate for these limitations by relying primarily on our U.S. GAAP results and using EBITDA and Adjusted EBITDA on a supplemental basis. You should review the reconciliation of net income (loss) to EBITDA and Adjusted EBITDA below and not rely on any single financial measure to evaluate our business.

The following table reconciles net loss to EBITDA and Adjusted EBITDA (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income (loss)	$	(35,653)	$	33,845	$	(5,680)	$	15,746
Interest (income) expense, net	(279)		254		(350)		5,249
Income tax expense	—		—		526		—
Depreciation and amortization	839		302		2,445		671
EBITDA	$	(35,093)	$	34,401	$	(3,059)	$	21,666
Adjusted for:
Change in fair value of private placement warrant liability	(3,447)		(7,614)		(13,385)		(7,614)
Change in fair value of earnout liability	(18,034)		(73,359)		(87,371)		(73,359)
Gain (loss) on equity securities	—		—		(10,082)		—
Stock-based compensation	1,063		14,766		4,115		15,644
Executive transition charges (1)	517		13,860		517		13,860
Business combination transaction expenses (2)	—		3,404		—		3,404
Regulatory and legal matters (3)	7,859		111		13,362		111
Orten business combination cancellation	8,440		—		8,440		—
Adjusted EBITDA	$	(38,695)	$	(14,431)	$	(87,463)	$	(26,288)

(1)The 2022 executive transition charges include a separation payment and salary expense for technical advisory services related to the former Executive Chairman. The 2021 executive transition charges include stock-based compensation costs of $13.4 million and salary expense of $0.5 million related to former CTO’s retirement.

(2)Transaction costs of $3.3 million attributable to the liability classified earnout shares and $0.1 million of write-off of debt issuance costs.

(3)Regulatory and legal matters include legal, advisory, and other professional service fees incurred in connection with the short-seller analyst article from September 2021, and investigations and litigation related thereto.

31

Liquidity

The Company incurred net loss of $35.7 million and $5.7 million for the three and nine months ended September 30, 2022, respectively. The Company reported net income of $33.8 million and $15.7 million for the three and nine months ended September 30, 2021, respectively. Net cash used in operating activities was $116.2 million and $52.2 million for the nine months ended September 30, 2022 and 2021, respectively. As of September 30, 2022, we had $70.6 million in cash and cash equivalents, $239.6 million in short-term investments, and positive working capital of $344.2 million. The Business Combination closed on July 16, 2021, generated proceeds of approximately $509.0 million of cash, net of transaction costs and redemptions. We believe that our current cash balance will provide adequate liquidity during the 12-month period from the issuance date of these unaudited interim consolidated financial statements.

As an early stage growth company, the Company expects to continue to incur net losses in the near term. As the Company commenced its internal restructuring effort in 2022, the primary focuses are the advancement of its proprietary fuel cell technology and development and commercialization of single heavy duty commercial vehicle platform in each region by leveraging third party contracted manufacturers. Until the Company can generate sufficient revenue from product sales, retrofit services or lease arrangements to cover operating expenses, working capital and capital expenditures, the Company will need to raise additional capital. The Company expects to fund cash needs through a combination of equity and debt financing, including lease securitization, strategic collaborations, and licensing arrangements. If the Company cannot raise additional funds when needed, our financial condition, business, prospects, and results of operations could be materially adversely affected.

These financial statements have been prepared by management in accordance with U.S. GAAP and this basis assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. These financial statements do not include any adjustments that may result from the outcome of this uncertainty. As of the date of this Quarterly Report on Form 10-Q, management believes that the Company’s existing financial resources will be sufficient to execute its operating priorities for the next 12 months following the issuance date of these unaudited interim consolidated financial statements. As of March 31, 2023, unrestricted cash, cash equivalents, and short-term investments were approximately $210 million.

Short-Term Liquidity Requirements

As of the date of this filing, we believe our available liquidity and capital resources will be sufficient to continue to execute our business strategy over at least the next twelve-month period. This business strategy includes completing the development and commercial launch of our three focus FCEV truck platforms, successfully delivering additional FCEV trucks to customers and expanding our contracted customer pipeline, significantly advancing the commercialization of our 200 kW fuel cell system and manufacturing facility in Bolingbrook, IL, USA including continuing pre-sales of prototype 200 kW fuel cell systems, active management of our cost structure through the detailed cost and cash management plan that has been developed and is already in execution, and strategic hiring of critical personnel to deliver the above mentioned programs.

We have considered and assessed our ability to continue as a going concern for at least the one year from the date of this filing. We have undertaken certain actions to improve our cost structure, cash utilization focus and strategic alignment along with our pathway to cash flow breakeven during the last two quarters of 2022 and the first quarter of 2023:

•integrated our organization globally to drive efficiencies in all regions, including reprioritization of hiring plans;

•eliminated research and development programs deemed not vital to fuel cell and vehicle platform commercialization;

•significantly reduced the number of vehicle variants in development, focusing on three core vehicle platforms;

•halted commercial vehicle deliveries in China and restructured the China operation to align with the revised global strategic and execution priorities, which included a staff reduction of 17 employees;

•conducted multiple divestitures to monetize non-core assets or contracts and acquired 100% ownership of Hyzon Europe to drive further operational efficiencies in our European operation;

32

•identified optimizations in our business model that further reduce the working capital requirements for our fuel cell system manufacturing and vehicle assembling business.

However, actual results could vary materially and negatively as a result of a number of factors, including:

•our ability to manage the costs of manufacturing and servicing the FCEV trucks;

•revenue received from sales of our FCEV trucks and 200 kW fuel cell systems;

•the costs of expanding and maintaining our fuel cell manufacturing facility and equipment;

•our warranty claims experience should actual warranty claims differ significantly from estimates;

•the scope, progress, results, costs, timing and outcomes of the commercial development of our FCEV truck customer pipeline and conversion to contracts and deliveries;

•the timing and the costs involved in bringing our vehicles and 200 kW fuel cell systems to market;

•the costs of maintaining, expanding and protecting our intellectual property portfolio, including potential litigation costs and liabilities;

•the timely assembly of, delivery to customers and performance of our FCEV trucks and 200 kW fuel cell systems as it relates to receiving revenue and expanding contracted revenue pipeline with customers;

•the costs of additional general and administrative personnel, including accounting and finance, legal and human resources, as well as costs related to litigation, investigations, or settlements;

•other risks discussed in the section entitled "Risk Factors."

Long-Term Liquidity Requirements

Until we can generate sufficient revenue from truck sales and leases and fuel cell sales to cover operating expenses, working capital and capital expenditures, we expect to fund cash needs through a combination of equity and debt financing, including lease securitization, strategic collaborations, and licensing arrangements. If we raise funds by issuing equity securities, dilution to stockholders may result. Any equity securities issued may also provide for rights, preferences or privileges senior to those of holders of our common stock. If we raise funds by issuing debt securities, these debt securities may have rights, preferences and privileges senior to those of holders of our common stock. The terms of debt securities or borrowings could impose significant restrictions on our operations. If we raise funds through collaborations and licensing arrangements, we might be required to relinquish significant rights to our technologies or products, or grant licenses on terms that are not favorable to us. The credit market and financial services industry have in the past, and may in the future, experience periods of upheaval that could impact the availability and cost of equity and debt financing.

While we intend to raise additional capital in the future, if adequate funds are not available, we will need to reevaluate our expansion plans or limit our research and development activities, which could have a material adverse impact on our business prospects.

Debt

As of September 30, 2022 and December 31, 2022, we have no debt. The convertible notes and accrued interest in the comparative period, were converted to 5,022,052 shares of common stock upon close of the Business Combination.

33

Cash Flows

	Nine Months Ended September 30,
	2022		2021
Net cash used in operating activities	$	(116,218)	$	(52,242)
Net cash used in investing activities	(250,652)		(17,635)
Net cash (used in) provided by financing activities	(3,944)		554,165

Cash Flows for the Nine Months Ended September 30, 2022 and September 30, 2021

Cash Flows from Operating Activities

Net cash used in operating activities was $116.2 million for the nine months ended September 30, 2022, as compared to $52.2 million for the nine months ended September 30, 2021. The cash flows used in operating activities for the nine months ended September 30, 2022 were primarily driven by a net loss of $5.7 million and adjustments for certain non-cash items and changes in operating assets and liabilities. Non-cash gain adjustments consisted of changes in fair value of the private placement warrant liability of $13.4 million, earnout liability of $87.4 million, and equity securities of $10.1 million. These non-cash gain adjustments were partially offset by $4.1 million stock-based compensation expense and $2.4 million in depreciation and amortization. Changes in operating assets and liabilities were primarily driven by an increase of $16.8 million in inventory balances, an increase in accrued liabilities of $11.7 million, a decrease in accounts receivable of $2.7 million and a decrease of $1.6 million in prepayments for vehicle inventory, other supplier deposits and D&O insurance.

Net cash used in operating activities for the nine months ended September 30, 2021 was primarily driven by net income of $15.7 million and adjustments for certain non-cash items and changes in operating assets and liabilities. Non-cash gain adjustments primarily consisted of changes in fair value of the private placement warrant of $7.6 million and earnout liabilities of $73.4 million. These non-cash gain adjustments were partially offset by $29.0 million stock-based compensation expense and $0.7 million in depreciation and amortization. Changes in operating assets and liabilities were primarily driven by $19.6 million in prepayments for vehicle inventory, other supplier deposits and D&O insurance, an increase in accounts receivable of $5.7 million, and $12.0 million in inventory purchases.

Cash Flows from Investing Activities

Net cash used in investing activities was $250.7 million for the nine months ended September 30, 2022, as compared to $17.6 million for the nine months ended September 30, 2021. The cash flows used in investing activities for the nine months ended September 30, 2022 were driven by $11.3 million in property and equipment purchases, $313.0 million in purchase of short-term investments, offset by $73.7 million in proceeds from maturities of short-term investments. The cash flows used in investing activities for the nine months ended September 30, 2021 were due to $8.8 million in capital expenditures, as well as $4.0 million in machinery and equipment deposits to begin production of hydrogen fuel cell systems and assembly of hydrogen storage systems and $4.8 million of investments in equity securities of NRG and Raven SR. The $8.8 million in capital expenditures were primarily comprised of approximately $2.3 million related to acquiring a facility near Rochester, NY and $4.9 million in machinery equipment.

Cash Flows from Financing Activities

Net cash used in financing activities was $3.9 million for the nine months ended September 30, 2022, as compared to $554.2 million net cash provided by financing activities for the nine months ended September 30, 2021. The cash flows used in financing activities for the nine months ended September 30, 2022 were driven primarily by a $3.1 million payment towards the Horizon IP Agreement. The cash flows provided by financing activities for the nine months ended September 30, 2021 were driven primarily by $509.0 million in proceeds from the Business Combination, net of transaction costs and redemption, and $45.0 million in proceeds from issuance of convertible notes.

34

Contractual Obligations and Commitments

For the nine months ended September 30, 2022, there were no material changes outside the ordinary course of business within the Contractual Obligations table as previously disclosed in our amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021.

Off-Balance Sheet Arrangements

We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.

Critical Accounting Policies and Estimates

There have been no substantial changes to these estimates, or the policies related to them for the nine months ended September 30, 2022. For a full discussion of these estimates and policies, see "Critical Accounting Policies and Estimates" in Item 7 of our amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021.

Emerging Growth Company Status

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. Hyzon elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, Hyzon, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard, until such time Hyzon is no longer considered to be an emerging growth company. At times, Hyzon may elect to early adopt a new or revised standard.

In addition, Hyzon intends to rely on the other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an emerging growth company, Hyzon intends to rely on such exemptions, Hyzon is not required to, among other things: (a) provide an auditor’s attestation report on Hyzon’s system of internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act; (b) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act; (c) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis); and (d) disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation.

Hyzon will remain an emerging growth company under the JOBS Act until the earliest of (a) the last day of Hyzon’s first fiscal year following the fifth anniversary of the closing of DCRB’s initial public offering, (b) the last date of Hyzon’s fiscal year in which Hyzon has total annual gross revenue of at least $1.07 billion, (c) the date on which Hyzon is deemed to be a “large accelerated filer” under the rules of the SEC with at least $700.0 million of outstanding securities held by non-affiliates or (d) the date on which Hyzon has issued more than $1.0 billion in non-convertible debt securities during the previous three years.

35

Material Transactions with Related Parties

Horizon Supply Agreement

The Company made deposit payments to Horizon and its subsidiaries to procure certain fuel cell components. As of September 30, 2022, the remaining balance is $6.0 million and included within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance Sheets.

Certain employees of Horizon and its subsidiaries provide research and development, staff training, and administrative services to the Company. Based on an analysis of the compensation costs incurred by Horizon and an estimate of the proportion of effort spent by such employees on each entity, an allocation of approximately $0.4 million and $1.2 million was recorded in the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the three months ended September 30, 2022, and 2021, respectively. An allocation of approximately $0.9 million and $1.8 million was recorded in the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the nine months ended September 30, 2022, and 2021, respectively.

The related party payable to Horizon and its subsidiaries is $0.1 million and $3.7 million as of September 30, 2022 and December 31, 2021, respectively.

Holthausen and Affiliates

The Company entered into a joint venture agreement in October 2020 to create Hyzon Europe with Holthausen Clean Technology Investments B.V. (“Holthausen”). As Hyzon Europe builds out its production facilities, it relies on Holthausen and its affiliates for certain production resources that result in related party transactions. In addition, both companies rely on certain suppliers, including Horizon.

The Company currently owns 50.5% of the equity interests of Hyzon Europe. On December 31, 2021, Hyzon executed a non-binding Letter of Intent (“LOI”) with Holthausen to increase its stake to 75% in Hyzon Europe. Concurrent with the signing of this LOI, a €1 million refundable deposit was paid to Holthausen, approximately $1.1 million in U.S. dollars (“USD”). This deposit is recorded within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance Sheets.

Subsequently, in December 2022, the Company acquired the remaining 49.5% of the equity interests of Hyzon Europe from Holthausen. The Company now holds 100% ownership in Hyzon Europe. The Company paid €3.5 million (approximately $3.7 million in USD) in addition to €1.0 million (approximately $1.1 million in USD) paid in December 2021. As part of this transaction, the Company also transferred various inventory items to, and settled open related party balances with, Holthausen. In addition, the Company reassigned all of the assumed retrofit service contracts, including after-sales obligations, back to Holthausen Clean Technology B.V.

For the three and nine months ended September 30, 2022, the Company paid $0.1 million and $0.4 million, respectively, to Carl Holthausen and Max Holthausen as managing directors of Hyzon Europe. For the three and nine months ended September 30, 2021, the Company paid $0.1 million and $0.3 million, respectively.

As of September 30, 2022, the related party payable to Holthausen is $0.1 million. As of December 31, 2021, the related party receivable from Holthausen is $0.3 million.

Jiushuang Joint Ventures

As described in Note 3. Revenue, the Company delivered 20 FCEVs to Jiushuang (Shanghai) New Energy Technology Co., Ltd. during the three months ended September 30, 2022. Jiushuang (Shanghai) New Energy Technology Co., Ltd. is a parent of both Jiushuang Tiancheng Motors Service Ltd. (“JSTC”) and Jiushuang Suda Logistics Ltd. (“JSSD”), which the Company partnered with to form the Jiushuang joint ventures.

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined in Rule 12b-2 under the Exchange Act. As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required by this Item.

36

Item 4.    Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

The term disclosure controls and procedures means controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Interim Chief Financial Officer to allow timely decisions regarding required disclosure.

We do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all instances of fraud due to inherent limitation of internal controls. Because of these inherent limitations there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

Our Chief Executive Officer and Interim Chief Financial Officer have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of September 30, 2022. Based on such evaluation, our Chief Executive Officer and Interim Chief Financial Officer have concluded that as of September 30, 2022 our disclosure controls and procedures were not effective because of the material weaknesses in internal control over financial reporting described below.

In light of the material weaknesses described below, our management has performed additional analyses, reconciliations, and other post-closing procedures and has concluded that, notwithstanding the ineffectiveness of our disclosure controls and procedures as well as material weaknesses in our internal control over financial reporting as of September 30, 2022, the unaudited interim consolidated financial statements for the periods covered by and included in this Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows as of and for the periods presented in conformity with U.S. GAAP.

(b) Material Weaknesses in Internal Control over Financial Reporting

While preparing the Company’s unaudited interim consolidated financial statements, our management concluded that the following material weaknesses in internal control over financial reporting disclosed in our amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021 are not fully remediated:

•The Company did not demonstrate a commitment to attract, develop, and retain competent individuals in alignment with objectives and accordingly did not have sufficient qualified resources.

•The Company did not have an effective risk assessment process that successfully identified and assessed risks of material misstatement to ensure controls were designed and implemented to respond to those risks.

•The Company did not have an effective internal information and communication process to ensure that relevant and reliable information was communicated on a timely basis across the organization, to enable financial personnel to effectively carry out their financial reporting and internal control roles and responsibilities.

•The Company did not sufficiently establish structures, reporting lines and appropriate authorities and responsibilities in the pursuit of objectives.

As a consequence, the Company did not effectively design, implement and operate process-level control activities related to revenue recognition, complex accounting transactions, and the financial close process to mitigate risks to an acceptable level.

Because there is a reasonable possibility that material misstatements of the unaudited interim consolidated financial statements will not be prevented or detected on a timely basis, we concluded that these deficiencies represent material weaknesses in our internal control over financial reporting and that our internal control over financial reporting was not effective as of September 30, 2022.

37

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that material misstatements of our annual or interim financial statements will not be prevented or detected on a timely basis. These deficiencies could result in misstatements to our financial statements that would be material and would not be prevented or detected on a timely basis.

(c) Remediation Plan and Status

With oversight from the Audit Committee and input from the Board of Directors, management has begun designing and implementing changes in processes and controls to remediate the material weaknesses described above. Management and the Board of Directors, including the Audit Committee, are working to remediate the material weaknesses identified herein. While the Company expects to take other remedial actions, actions taken to date include:

•appointed a new Chief Executive Officer and Interim Chief Financial Officer and created new roles of President of International Operations, President of North America and Chief Operating Officer.

•hired additional finance and accounting personnel over time to augment our accounting staff, including third-party resources with the appropriate technical accounting expertise;

•engaged with external consultants with public company and technical accounting experience to facilitate accurate and timely accounting closes and to accurately prepare and review the unaudited interim consolidated financial statements and related footnote disclosures;

•established a Disclosure Committee and implemented controls and procedures for the disclosure of Company data and information, as well as roles and responsibilities for formal review and sign off process; and

•implemented a formal regional general manager financial statement review and certification process for each SEC filing.

In addition to the remedial actions taken to date, the Company is taking, or plans to take, the following actions to remediate the material weaknesses identified herein:

•designing and implementing a comprehensive and continuous risk assessment process to identify and assess risks of material misstatements and to ensure that the impacted financial reporting processes and related internal controls are properly designed, maintained, and documented to respond to those risks in our financial reporting;

•further developing and implementing formal policies, processes and documentation procedures relating to financial reporting, including revenue recognition and other complex accounting matters, and consulting with independent accounting experts and advisors;

•formalizing the design of the processes and controls related to sales of our products and services, as well as vendor contracting, fuel cell acceptance, transfer of control of our products to customers, tracking our vehicles' post-sale performance, and archiving documentation in a central system; and

•completing ethics training globally and in addition, providing general public company periodic training for Company personnel, including on potential topics such as the responsibilities of a public company, the core values of the Company’s accounting and finance function, and best practices to implement those values.

As we work to improve our internal control over financial reporting, we will report regularly to the Company’s Audit Committee on the progress and results of the remediation plan, including the identification, status, and resolution of internal control deficiencies. We may modify our remediation plan and may implement additional measures as we continue to review, optimize and enhance our financial reporting controls and procedures in the ordinary course. We will not be able to fully remediate these material weaknesses until these steps have been completed and have been operating effectively for a sufficient period of time. If we are unable to successfully remediate the material weaknesses, or if in the future, we identify further material weaknesses in our internal control over financial reporting, we may not detect errors on a timely basis and our unaudited interim consolidated financial statements may be materially misstated.

38

(d) Changes in Internal Control over Financial Reporting

There have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2022, that have materially affected, or are reasonably likely to affect, our internal control over financial reporting.

39

PART II – OTHER INFORMATION

Item 1.    Legal Proceedings

The information set forth under Note 12. Commitments and Contingencies, to our unaudited interim consolidated financial statements of this quarterly report on Form 10-Q is incorporated by reference in answer to this item. Such information is limited to certain recent developments.

Item 1A.    Risk Factors

In addition to the other information discussed in this report, please consider the factors described in Part I, Item 1A., “Risk Factors” in our Annual Report filed on Form 10-K for the year ended December 31, 2021, as amended by Amendment No.1 on Form 10-K/A, that could materially affect our business, financial condition or future results. There have not been any material changes to the risk factors described in our 2021 Form 10-K as amended, except for the additional risks noted below, but these are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may adversely affect our business, financial condition or operating results.

Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations, financial condition and results of operations.

Events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (“FDIC”) as receiver. Similarly, on March 12, 2023, Signature Bank and Silvergate Capital Corp. were each swept into receivership.

Our available cash and cash equivalents are held in accounts with or managed by financial institutions and consist of cash in our operating accounts and cash and cash equivalents. The amount of cash in our operating accounts exceeds the Federal Deposit Insurance Corporation insurance limits. While we monitor our accounts regularly and adjust our balances as appropriate, the valuation of or our access to these accounts could be negatively impacted if the underlying financial institutions fail or become subject to other adverse conditions in the financial markets. The operations of U.S. and global financial services institutions are interconnected and the performance and financial strength of specific institutions are subject to rapid change, the timing and extent of which cannot be known. To date, we have experienced no realized losses on, or lack of access to, our cash held in operating accounts or our invested cash or cash equivalents as a result of adverse conditions in the financial markets or with respect to financial institutions; however, we can provide no assurance that access to our cash held in operating accounts or our invested cash and cash equivalents will not be impacted by such adverse conditions in the future.

Although we assess our banking and customer relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect us, the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we have financial or business relationships but could also include factors involving financial markets or the financial services industry generally.

In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or fulfill our other obligations, result in breaches of our contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our business, financial condition or results of operations.

40

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

There were no sales of equity securities for the nine months ended September 30, 2022 that were not registered under the Securities Act.

Item 3.    Defaults Upon Senior Securities

None.

Item 4.    Mine Safety Disclosures

Not applicable.

Item 5.    Other Information

None.

41

Item 6.    Exhibits

Exhibit Number	Description
3.1	Second Amended and Restated Certificate of Incorporation of Hyzon (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 22, 2021)
3.2	Amended and Restated Bylaws of Hyzon (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the SEC on July 22, 2021)
10.1	Cancellation Agreement with Orten Holding GmbH, dated September 29, 2022 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on October 5, 2022)
31.1	Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)
31.2	Certification of Interim Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)
32.1*	Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
32.2*	Certification of Interim Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
101.INS	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

_________________________

*    This information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act.

#    Indicates management contract or compensatory arrangement.

† Filed or furnished herewith.

42

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Hyzon Motors Inc.
Date: May 1, 2023	By:	/s/ Parker Meeks
	Name:	Parker Meeks
	Title:	Chief Executive Officer
Date: May 1, 2023	By:	/s/ Jiajia Wu
	Name:	Jiajia Wu
	Title:	Interim Chief Financial Officer and Chief Accounting Officer

43

EX-31.1

Exhibit 31.1

Certification Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a)

as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Parker Meeks, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 of Hyzon Motors Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 1, 2023	/s/ Parker Meeks
	Parker Meeks Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a)

as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Jiajia Wu, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 of Hyzon Motors Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 1, 2023	/s/ Jiajia Wu
	Jiajia Wu
	Interim Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350 as Adopted

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Parker Meeks, Chief Executive Officer of Hyzon Motors Inc. (the “Company”), hereby certify, that, to my knowledge:

1.The Quarterly Report on Form 10-Q for the period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 1, 2023	/s/ Parker Meeks
	Parker Meeks Chief Executive Officer (Principal Executive Officer)

EX-32.2

Exhibit 32.2

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Jiajia Wu, Interim Chief Financial Officer of Hyzon Motors Inc. (the “Company”), hereby certify, that, to my knowledge:

1.The Quarterly Report on Form 10-Q for the period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 1, 2023	/s/ Jiajia Wu
	Jiajia Wu
	Interim Chief Financial Officer
	(Principal Financial Officer)

XML

Cover - shares	9 Months Ended
	Sep. 30, 2022	Mar. 31, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity Registrant Name	Hyzon Motors Inc.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-39632
Entity Tax Identification Number	82-2726724
Entity Address, Address Line One	475 Quaker Meeting House Road
Entity Address, City or Town	Honeoye Falls
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	14472
City Area Code	585
Local Phone Number	484-9337
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		244,561,073
Entity Central Index Key	0001716583
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	HYZN
Security Exchange Name	NASDAQ
Warrant
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
Trading Symbol	HYZNW

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 70,602	$ 445,146
Short-term investments	239,648	0
Accounts receivable	48	2,956
Related party receivable	64	264
Inventory	39,825	20,927
Prepaid expenses and other current assets	24,070	26,852
Total current assets	374,257	496,145
Property, plant, and equipment, net	24,869	14,346
Right-of-use assets	9,250	10,265
Investments in equity securities	15,030	4,948
Other assets	7,690	4,575
Total Assets	431,096	530,279
Current liabilities
Accounts payable	8,033	7,980
Accrued liabilities	18,586	6,770
Related party payables	399	3,695
Contract liabilities	784	10,925
Current portion of lease liabilities	2,212	1,886
Total current liabilities	30,014	31,256
Long term liabilities
Lease liabilities	7,585	8,830
Private placement warrant liability	1,843	15,228
Earnout liability	16,390	103,761
Deferred income taxes	526	0
Other liabilities	5,774	1,139
Total liabilities	62,132	160,214
Commitments and contingencies (Note 12)
Stockholders’ Equity
Common stock, $0.0001 par value; 400,000,000 shares authorized, 248,153,362 and 247,758,412 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.	25	25
Additional paid-in capital	404,436	400,826
Accumulated deficit	(15,731)	(26,412)
Accumulated other comprehensive (loss) income	(300)	378
Total Hyzon Motors Inc. stockholders’ equity	388,430	374,817
Noncontrolling interest	(19,466)	(4,752)
Total Stockholders’ Equity	368,964	370,065
Total Liabilities and Stockholders’ Equity	$ 431,096	$ 530,279

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021	Jul. 16, 2021
Statement of Financial Position [Abstract]
Common stock, par value (dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	248,153,362	247,758,412
Common stock, shares outstanding (In shares)	248,153,362	247,758,412

XML

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue	$ 5	$ 89	$ 2,939	$ 89
Operating expense:
Cost of revenue	8,203	204	10,226	204
Research and development	9,241	3,982	26,660	8,081
Selling, general, and administrative	36,103	42,661	75,920	51,607
Total operating expenses	53,547	46,847	112,806	59,892
Loss from operations	(53,542)	(46,758)	(109,867)	(59,803)
Other income (expense):
Change in fair value of private placement warrant liability	3,447	7,614	13,385	7,614
Change in fair value of earnout liability	18,034	73,359	87,371	73,359
Gain (loss) on equity securities	0	0	10,082	0
Foreign currency exchange loss and other income	(3,871)	(116)	(6,475)	(175)
Interest income (expense), net	279	(254)	350	(5,249)
Total other income (expense)	17,889	80,603	104,713	75,549
Net income (loss) before income taxes	(35,653)	33,845	(5,154)	15,746
Income tax expense	0	0	526	0
Net income (loss)	(35,653)	33,845	(5,680)	15,746
Less: Net loss attributable to noncontrolling interest	(10,858)	(776)	(16,361)	(1,307)
Net income (loss) attributable to Hyzon	(24,795)	34,621	10,681	17,053
Comprehensive income (loss):
Net income (loss)	(35,653)	33,845	(5,680)	15,746
Foreign currency translation adjustment	862	(187)	838	(273)
Debt Securities, Available-for-Sale, Unrealized Loss	131	0	131	0
Comprehensive income (loss)	(34,660)	33,658	(4,711)	15,473
Less: Comprehensive loss attributable to noncontrolling interest	(9,705)	(749)	(14,714)	(1,269)
Comprehensive income (loss) attributable to Hyzon	$ (24,955)	$ 34,407	$ 10,003	$ 16,742
Net income (loss) per share attributable to Hyzon:
Basic (dollars per share)	$ (0.10)	$ 0.15	$ 0.04	$ 0.09
Diluted (dollars per share)	$ (0.10)	$ 0.14	$ 0.04	$ 0.08
Weighted average common shares outstanding:
Basic (in shares)	248,164,000	234,091,000	248,054,000	189,101,000
Diluted (in shares)	248,164,000	246,480,000	257,828,000	200,984,000

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Previously Reported	Legacy Common Stock	Legacy Common Stock Previously Reported	Legacy Common Stock Revision of Prior Period, Adjustment	Common Stock Legacy Common Stock	Common Stock Legacy Common Stock Previously Reported	Common Stock Legacy Common Stock Revision of Prior Period, Adjustment	Common Stock Common Stock Class A	Common Stock Common Stock Class A Previously Reported	Common Stock Common Stock Class A Revision of Prior Period, Adjustment	Additional Paid-in Capital	Additional Paid-in Capital Previously Reported	Additional Paid-in Capital Revision of Prior Period, Adjustment	Retained Earnings (Accumulated Deficit)	Retained Earnings (Accumulated Deficit) Previously Reported	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Previously Reported	Total Hyzon Motors Inc. Stockholders’ Equity (Deficit)	Total Hyzon Motors Inc. Stockholders’ Equity (Deficit) Previously Reported	Noncontrolling Interest	Noncontrolling Interest Previously Reported
Legacy Common Stock outstanding, beginning balance (in shares) at Dec. 31, 2020			0	93,750,000	(93,750,000)
Legacy Common Stock Outstanding, beginning balance at Dec. 31, 2020						$ 0	$ 94	$ (94)
Legacy Common Stock outstanding, ending balance (in shares) at Jun. 30, 2021			0
Legacy Common Stock Outstanding, ending balance at Jun. 30, 2021						0
Beginning Balance (in shares) at Dec. 31, 2020									166,125,000	0	166,125,000
Beginning Balance at Dec. 31, 2020	$ 14,761	$ 14,761							$ 17	$ 0	$ 17	$ 29,122	$ 29,045	$ 77	$ (14,271)	$ (14,271)	$ (16)	$ (16)	$ 14,852	$ 14,852	$ (91)	$ (91)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)									132,900
Exercise of stock options	190											190							190
Stock-based compensation	816											816							816
IP transaction - deemed distribution	(10,000)											(10,000)							(10,000)
Net income attributable to Hyzon	(17,568)														(17,568)				(17,568)
Less: Net loss attributable to noncontrolling interest	(531)																				(531)
Foreign currency translation income (loss)	(68)																(79)		(79)		11
Ending Balance at Jun. 30, 2021	(12,400)								$ 17			20,128			(31,839)		(95)		(11,789)		(611)
Ending Balance (in shares) at Jun. 30, 2021									166,257,900
Legacy Common Stock outstanding, beginning balance (in shares) at Dec. 31, 2020			0	93,750,000	(93,750,000)
Legacy Common Stock Outstanding, beginning balance at Dec. 31, 2020						0	$ 94	$ (94)
Legacy Common Stock outstanding, ending balance (in shares) at Sep. 30, 2021			0
Legacy Common Stock Outstanding, ending balance at Sep. 30, 2021						0
Beginning Balance (in shares) at Dec. 31, 2020									166,125,000	0	166,125,000
Beginning Balance at Dec. 31, 2020	14,761	$ 14,761							$ 17	$ 0	$ 17	29,122	$ 29,045	$ 77	(14,271)	$ (14,271)	(16)	$ (16)	14,852	$ 14,852	(91)	$ (91)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to Hyzon	17,053
Less: Net loss attributable to noncontrolling interest	(1,307)
Ending Balance at Sep. 30, 2021	401,141								$ 25			400,021			2,782		(327)		402,501		(1,360)
Ending Balance (in shares) at Sep. 30, 2021									247,500,505
Legacy Common Stock outstanding, beginning balance (in shares) at Jun. 30, 2021			0
Legacy Common Stock Outstanding, beginning balance at Jun. 30, 2021						0
Legacy Common Stock outstanding, ending balance (in shares) at Sep. 30, 2021			0
Legacy Common Stock Outstanding, ending balance at Sep. 30, 2021						$ 0
Beginning Balance (in shares) at Jun. 30, 2021									166,257,900
Beginning Balance at Jun. 30, 2021	(12,400)								$ 17			20,128			(31,839)		(95)		(11,789)		(611)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)									221,500
Exercise of stock options	250											250							250
Common stock issued, shares (in shares)									7,234,006
Stock-based compensation	28,146											28,146							28,146
Vesting of RSUs (in shares)									284,796
Net income attributable to Hyzon	34,621														34,621				34,621
Less: Net loss attributable to noncontrolling interest	(776)																				(776)
Foreign currency translation income (loss)	(205)																(232)		(232)		27
Ending Balance at Sep. 30, 2021	401,141								$ 25			400,021			2,782		(327)		402,501		(1,360)
Ending Balance (in shares) at Sep. 30, 2021									247,500,505
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reverse Recapitalization Of Shares, Value	351,505								$ 7			351,498							351,505
Reverse Recapitalization Of Shares									73,502,303
Common stock issued, value									$ 1			(1)
Beginning Balance (in shares) at Dec. 31, 2021						0			247,758,412
Beginning Balance at Dec. 31, 2021	370,065					$ 0			$ 25			400,826			(26,412)		378		374,817		(4,752)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)									35,324
Exercise of stock options	40											40							40
Stock-based compensation	3,052											3,052							3,052
Vesting of RSUs (in shares)									168,772
Net share settlement of equity awards	(463)											(463)							(463)
Common stock issued for the cashless exercise of warrants (in shares)									44,349
Repurchase of warrants	(31)											(31)							(31)
Net income attributable to Hyzon	35,476														35,476				35,476
Less: Net loss attributable to noncontrolling interest	(5,503)																				(5,503)
Foreign currency translation income (loss)	(24)																(518)		(518)		494
Ending Balance at Jun. 30, 2022	402,612					$ 0			$ 25			403,424			9,064		(140)		412,373		(9,761)
Ending Balance (in shares) at Jun. 30, 2022						0			248,006,857
Beginning Balance (in shares) at Dec. 31, 2021						0			247,758,412
Beginning Balance at Dec. 31, 2021	370,065					$ 0			$ 25			400,826			(26,412)		378		374,817		(4,752)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to Hyzon	10,681
Less: Net loss attributable to noncontrolling interest	(16,361)
Ending Balance at Sep. 30, 2022	368,964					$ 0			$ 25			404,436			(15,731)		(300)		388,430		(19,466)
Ending Balance (in shares) at Sep. 30, 2022						0			248,153,362
Beginning Balance (in shares) at Jun. 30, 2022						0			248,006,857
Beginning Balance at Jun. 30, 2022	402,612					$ 0			$ 25			403,424			9,064		(140)		412,373		(9,761)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)									3,544
Exercise of stock options	4											4							4
Stock-based compensation	1,063											1,063							1,063
Vesting of RSUs (in shares)									133,980
Net share settlement of equity awards	(55)											(55)							(55)
Common stock issued for the cashless exercise of warrants (in shares)									8,981
Repurchase of warrants	131																131		131
Net income attributable to Hyzon	(24,795)														(24,795)				(24,795)
Less: Net loss attributable to noncontrolling interest	(10,858)																				(10,858)
Foreign currency translation income (loss)	862																(291)		(291)		1,153
Ending Balance at Sep. 30, 2022	$ 368,964					$ 0			$ 25			$ 404,436			$ (15,731)		$ (300)		$ 388,430		$ (19,466)
Ending Balance (in shares) at Sep. 30, 2022						0			248,153,362

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (5,680)	$ 15,746
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	2,445	671
Stock-based compensation	4,115	29,023
Loss on extinguishment of convertible notes	0	107
Deferred income tax expense	526	0
Accretion of discount on available-for-sale securities	(185)	0
Noncash interest expense	0	5,449
Fair value adjustment of private placement warrant liability	(13,385)	(7,614)
Change in fair value of earnout liability	(87,371)	(73,359)
(Gain) loss on equity securities	(10,082)	0
Equity method investment loss	72	0
Changes in operating assets and liabilities:
Accounts receivable	2,676	(5,712)
Inventory	(16,776)	(12,008)
Prepaid expenses and other current assets	1,621	(19,638)
Other assets	(383)	(150)
Accounts payable	289	3,371
Accrued liabilities	11,678	3,082
Related party payables, net	31	3,821
Contract liabilities	(5,053)	4,845
Other liabilities	(756)	124
Net cash used in operating activities	(116,218)	(52,242)
Cash Flows from Investing Activities:
Purchases of property and equipment	(11,320)	(8,810)
Advanced payments for capital expenditures	0	(3,999)
Purchases of short-term investments	(313,032)	0
Proceeds from maturities of short-term investments	73,700	0
Investment in equity securities	0	(4,826)
Net cash used in investing activities	(250,652)	(17,635)
Cash Flows from Financing Activities:
Proceeds from Business Combination, net of redemption and transaction costs	0	508,993
Exercise of stock options	44	440
Payment of finance lease liability	(294)	(135)
Debt issuance costs	0	(133)
Proceeds from issuance of convertible notes	0	45,000
Net share settlement of equity awards	517
Payment under Horizon IP agreement	(3,146)
Repurchase of warrants	(31)	0
Net cash (used in) provided by financing activities	(3,944)	554,165
Effect of exchange rate changes on cash	(967)	(853)
Net change in cash, cash equivalents, and restricted cash	(371,781)	483,435
Cash, cash equivalents, and restricted cash — Beginning	449,365	17,139
Cash, cash equivalents, and restricted cash — Ending	77,584	500,574
Lease assets obtained in exchange for lease obligations:
Operating leases	0	6,803
Finance leases	0	0
Conversion of Legacy Hyzon common stock	0	73
Recognition of earnout liability in Business Combination	0	188,373
Recognition of private placement warrant liability in Business Combination	0	19,395
Horizon license agreement payable	0	10,000
Conversion of convertible notes for common stock	$ 0	$ 50,198

XML

Nature of Business and Basis of Presentation

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Business and Basis of Presentation

Nature of Business and Basis of Presentation

Description of Business

Hyzon Motors Inc. (“Hyzon” or the “Company”), headquartered in Honeoye Falls, New York, is commercializing its proprietary heavy-duty fuel cell technology through manufacturing and retrofitting heavy-duty hydrogen fuel cell electric vehicles (“FCEVs”) in the United States, Europe, and Australia. In addition, Hyzon builds and fosters a clean hydrogen supply ecosystem with leading partners from feedstocks through production, dispensing, and financing. The Company is majority-owned by Hymas Pte. Ltd. (“Hymas”), a Singapore company, which is majority-owned but indirectly controlled by Horizon Fuel Cell Technologies PTE Ltd., a Singapore company (“Horizon”).

Business Combination and Basis of Presentation

The accompanying unaudited interim consolidated financial statements and related disclosures have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the requirements and rules of the SEC regarding interim reporting. Certain notes or other information that are normally required by U.S. GAAP have been omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited interim consolidated financial statements should be read in connection with the Company’s audited consolidated financial statements and related notes included in the Company’s amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021.

The Company’s unaudited interim consolidated financial statements include the accounts and operations of the Company and its wholly owned subsidiaries including variable interest entity arrangements in which the Company is the primary beneficiary. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited interim consolidated financial statements include all normal and recurring adjustments necessary for a fair presentation for the periods presented. Results of operations reported for interim periods presented are not necessarily indicative of results for the entire year or any other periods.

On July 16, 2021 (the “Closing Date”), legacy Hyzon Motors Inc. and now named Hyzon Motors USA Inc., (“Legacy Hyzon”), consummated the transactions contemplated by the Business Combination Agreement and Plan of Reorganization (the “Business Combination”), dated February 8, 2021, with Decarbonization Plus Acquisition Corporation (“DCRB”) to effect a business combination between DCRB and Legacy Hyzon with DCRB Merger Sub Inc., a wholly owned subsidiary of DCRB, merging with and into Legacy Hyzon, with Legacy Hyzon surviving the merger as a wholly owned subsidiary of DCRB. On the Closing Date, DCRB changed its name to “Hyzon Motors Inc.” and Legacy Hyzon changed its name to “Hyzon Motors USA Inc.”

The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP, with no goodwill or other intangible assets recorded and the net assets of Legacy Hyzon consolidated with DCRB at historical cost. Under this method of accounting, DCRB is treated as the “acquired” company for financial reporting purposes.

Accordingly, the equity structure has been retrospectively adjusted in all comparative periods up to the Closing Date, to reflect the number of shares of the Company's common stock, $0.0001 par value per share issued to Legacy Hyzon's stockholders in connection with the reverse recapitalization. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Hyzon common stock prior to the Business Combination have been retroactively restated as shares reflecting an exchange ratio of 1.772 (the “Exchange Ratio”).

Liquidity

The Company incurred net losses of $35.7 million and $5.7 million for the three and nine months ended September 30, 2022, respectively. The Company generated net income of $33.8 million and $15.7 million for the three and nine months ended September 30, 2021, respectively. Accumulated deficit amounted to $15.7 million and $26.4 million as of September 30, 2022 and December 31, 2021, respectively. Net cash used in operating activities was $116.2 million and $52.2 million for the nine months ended September 30, 2022 and 2021, respectively.

On July 16, 2021, the Company received $509.0 million in cash, net of redemption and transaction costs as a result of the Business Combination. As of September 30, 2022, the Company has $70.6 million in unrestricted cash and cash equivalents, $239.6 million in short-term investments and $7.0 million in restricted cash. Restricted cash is pledged as security for letters of credit or other collateral amounts established by the Company for certain lease obligations, corporate credit cards, and other contractual arrangements. The Company’s restricted cash is included within Other assets in the unaudited interim Consolidated Balance Sheets.

As an early stage growth company, the Company expects to continue to incur net losses in the near term. As the Company commenced its internal restructuring effort in 2022, the primary focuses are the advancement of its proprietary fuel cell technology and development and commercialization of single heavy duty commercial vehicle platform in each region by leveraging third party contracted manufacturers. Until the Company can generate sufficient revenue from product sales, retrofit services or lease arrangements to cover operating expenses, working capital and capital expenditures, the Company will need to raise additional capital. The Company expects to fund cash needs through a combination of equity and debt financing, including lease securitization, strategic collaborations, and licensing arrangements. If the Company cannot raise additional funds when needed, our financial condition, business, prospects, and results of operations could be materially adversely affected.

These financial statements have been prepared by management in accordance with U.S. GAAP and this basis assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. These financial statements do not include any adjustments that may result from the outcome of this uncertainty. As of the date of this Quarterly Report on Form 10-Q, management believes that the Company’s existing financial resources will be sufficient to execute its operating priorities for the next 12 months following the issuance date of these unaudited interim financial statements. As of March 31, 2023, unrestricted cash, cash equivalents, and short-term investments were approximately $210 million.

Risks and Uncertainties

The Company is subject to a variety of risks and uncertainties common to early-stage companies with a history of losses and are expected to incur significant expenses and continuing losses for the foreseeable future. The risks and uncertainties include, but not limited to, further development of its technology, marketing and distribution channels, further development of its supply chain and manufacturing, development by competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, and the ability to secure additional capital to fund operations.

Reclassifications

Certain items previously reported in specific financial statement captions have been reclassified to conform to the current presentation in the consolidated financial statements and the accompanying notes.

Material Transactions

Orten Business Combination Cancellation

In June 2022, the Company entered into an agreement with the intention of acquiring 100% of outstanding ownership in Orten Betriebs GmbH and subsidiaries, and Orten Electric Trucks GmbH (collectively “Orten”). Subsequently, in September 2022, the Company terminated the agreement. As a result of the termination, the Company transferred consideration of €8.5 million (approximately $8.4 million in USD) to Orten consisting of €6.1 million (approximately $6.1 million in USD) in cash and €2.4 million (approximately $2.3 million in USD) in vehicle inventory. The amount of consideration transferred is included within Selling, general and administrative expense in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss).

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

The Company’s significant accounting policies are described in Note 3. Summary of Significant Accounting Policies, in the Company’s consolidated financial statements included in the Company’s amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021.

Except for the policies noted below, there have been no material changes to the significant accounting policies for the nine months ended September 30, 2022.

Cash Equivalents

The Company’s cash equivalents consist of short-term, highly liquid financial instruments that are readily convertible to cash with original maturities of three months or less. Due to their short-term nature, the amortized cost of the Company’s cash equivalents approximate fair value. As of September 30, 2022, cash equivalents consisted of commercial paper, certificates of deposit and money market funds totaling $40.6 million. The Company did not have any cash equivalents as of December 31, 2021.

Short-term Investments

The Company has short-term investments in marketable debt securities with an original maturity of greater than three months, but less than one year. These securities include certificates of deposit, commercial paper, corporate debt, foreign government bonds, and U.S. Treasury bills. The Company may sell these marketable debt securities prior to their stated maturities depending upon changing liquidity requirements. The Company’s marketable debt securities have been classified and accounted for as available-for-sale (“AFS”) marketable securities in accordance with ASC 326, Financial Instruments - Credit Losses. AFS securities are recorded at fair value as of each balance sheet date, with unrealized gains or losses included in Accumulated other comprehensive income (loss) and as a component of the Consolidated Statements of Operations and Comprehensive Income (Loss). Gains and losses as a result of sales or maturity of securities are reclassified from previously unrealized gains and losses on short-term investments in Accumulated other comprehensive income (loss) to Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Income (Loss).

For an AFS security with an amortized cost that exceeds its fair value, the Company first determines if it intends to sell or will more-likely-than-not be required to sell the security before the expected recovery of its amortized cost. If it intends to sell or will more-likely-than-not be required to sell the security, then the Company recognizes the impairment as a credit loss in the Consolidated Statements of Operations and Comprehensive Income (Loss) by writing down the security’s amortized cost to its fair value. If it does not intend to sell or it is not more-likely-than-not that it will be required to sell the security before the expected recovery of its amortized cost, the Company recognizes the portion of the impairment that is due to a credit loss, if any, in the Consolidated Statements of Operations and Comprehensive Income (Loss) through an allowance. The portion of the impairment that is due to factors other than a credit loss is recognized in Comprehensive income (loss) in the Consolidated Statements of Operations and Comprehensive Income (Loss) as an unrealized loss. Accrued interest receivable is excluded from the estimate of credit losses (see Note 9. Short-term Investments).

XML

Revenue

9 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

The Company recognized negligible revenue and $2.9 million in sales of hydrogen fuel cell systems in the United States, and sales of FCEVs in China, and retrofit services in Europe for the three and nine months ended September 30, 2022, respectively. The Company recognized revenue of $0.1 million for the three and nine months ended September 30, 2021.

In accordance with ASC 606, the Company is required to evaluate customers’ ability and intent to pay substantially all of the consideration to which the Company is entitled in exchange for the vehicles transferred to the customer, i.e., collectability of contracts with customers. The Company’s customers in China are special purpose entities established in response to China’s national hydrogen fuel cell vehicle pilot program. While in the Company’s estimation the customers have strong business plans and management teams, in consideration of the customers’ limited operating history and extended payment terms in their contracts, the Company determined the collectability criterion is not met with respect to contract existence under ASC 606 for either customer, and therefore, an alternative method of revenue recognition has been applied to each arrangement.

The $2.5 million of revenue recognized from sales of FCEVs in China related to the delivery of 62 FCEVS in the nine months ended September 30, 2022. This amount is equal to the remaining consideration received after satisfying local government VAT obligations, as such amounts are non-refundable and the Company has transferred control of the 62 FCEVs to which the consideration relates and has stopped transferring goods or services to the customer. During the three months ended September 30, 2022, the Company delivered 20 additional FCEVs to a different customer, however, no amounts were recognized as revenue as the consideration received was less than the amounts paid to satisfy local government VAT obligations. The Company will continue to monitor the customers and evaluate the collectability criterion as of each reporting period. The total cost of the 62 FCEVs delivered was recorded within Cost of revenue in the Consolidated Statements of Operations and Comprehensive Loss in 2021 since control of such FCEVs was transferred to the customer prior to December 31, 2021. The total cost of $2.9 million related to the additional 20 FCEVs was recorded within Cost of revenue in the Consolidated Statements of Operations and Comprehensive Income (Loss) during the three months ended September 30, 2022 since control of such FCEVs was transferred at the time of delivery.

Contract Balances

Contract liabilities relate to the advance consideration invoiced or received from customers for products and services prior to satisfying a performance obligation or in excess of amounts allocated to a previously satisfied performance obligation.

The current portion of contract liabilities is recorded within Contract liabilities in the Consolidated Balance Sheets and totaled $0.8 million and $10.9 million as of September 30, 2022 and December 31, 2021, respectively. The long-term portion of contract liabilities is recorded within Other liabilities in the Consolidated Balance Sheets and totaled $5.6 million and $1.0 million as of September 30, 2022 and December 31, 2021, respectively. As part of efforts to exit certain customer contracts, the Company refunded $0.1 million in the fourth quarter of 2022.

Remaining Performance Obligations

The transaction price associated with remaining performance obligations for commercial vehicles and other contracts with customers was $15.4 million as of September 30, 2022. The Company expects to recognize approximately 5% of its remaining performance obligations as revenue over the twelve months after September 30, 2022.

XML

Inventory

9 Months Ended

Sep. 30, 2022

Inventory Disclosure [Abstract]

Inventory

Inventory     

Inventory consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Raw materials	$	26,434	$	16,099
Work in process	13,391		4,828
Total inventory	$	39,825	$	20,927

The Company writes down inventory for any excess or obsolescence, or when the Company believes that the net realizable value of inventories is less than the carrying value. Inventory write-downs recognized in Cost of revenue were $2.3 million and $3.0 million for the three and nine months ended September 30, 2022, respectively. The Company did not write down any inventory for the three and nine months ended September 30, 2021, respectively.

XML

Prepaid Expenses and Other Current Assets

9 Months Ended

Sep. 30, 2022

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Deposit for fuel cell components (Note 15)	$	6,017	$	5,008
Vehicle inventory deposits	6,638		10,171
Production equipment deposits	242		1,169
Other prepaid expenses	4,673		3,266
Prepaid insurance	4,345		5,079
VAT receivable from government	2,155		2,159
Total prepaid expenses and other current assets	$	24,070	$	26,852

XML

Property, Plant, and Equipment, net

9 Months Ended

Sep. 30, 2022

Property, Plant and Equipment [Abstract]

Property, Plant, and Equipment, net

Property, Plant, and Equipment, net

Property, plant, and equipment, net consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Land and building	$	2,818	$	2,818
Machinery and equipment	16,197		8,827
Software	2,071		507
Leasehold improvements	1,356		746
Construction in progress	5,081		2,139
Total Property, plant, and equipment	27,523		15,037
Less: Accumulated depreciation and amortization	(2,654)		(691)
Property, plant and equipment, net	$	24,869	$	14,346

Depreciation and amortization expense totaled $0.8 million and $2.1 million for the three and nine months ended September 30, 2022, respectively. Depreciation and amortization expense totaled $0.2 million and $0.5 million for the three and nine months ended September 30, 2021, respectively.

XML

Accrued liabilities

9 Months Ended

Sep. 30, 2022

Payables and Accruals [Abstract]

Accrued liabilities

Accrued liabilities

Accrued liabilities consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Payroll and payroll related expenses	$	3,904	$	2,250
Accrued professional fees	5,325		2,450
Accrued product warranty costs	903		816
Accrued contract manufacturer costs	1,346		—
Accrued contract termination costs (Note 12)	2,430		—
Accrued Orten cancellation costs (Note 1)	1,617		—
Accrued severance	475		—
Other accrued expenses	2,586		1,254
Accrued liabilities	$	18,586	$	6,770

XML

Investments in Equity Securities

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Investment in Equity Securities

Investments in Equity Securities

The Company owns common shares, participation rights, and options to purchase additional common shares in certain private companies. On a non-recurring basis, the carrying value is adjusted for changes resulting from observable price changes in orderly transactions for identical or similar investments in the same issuer or an impairment.

Included in Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the nine months ended September 30, 2022 is a $12.5 million gain related to the equity investment in Raven SR, Inc. (“Raven”). The investment in Raven’s common shares and options were initially accounted for at cost of $2.5 million. In March 2022, there was an observable change in price of Raven’s common shares. The change in observable price of Raven’s common shares also results in a remeasurement of the investment in Raven’s options as of the date that the observable transaction took place. The fair value of the investment in Raven’s common shares was determined based on observable market prices of identical instruments in less active markets and is classified accordingly as Level 2 in the fair value hierarchy. Due to certain anti-dilution rights included in the options held by the Company, the fair value was determined utilizing a Monte-Carlo simulation model. Accordingly, this was determined to be a Level 3 measurement in the fair value hierarchy. The most significant assumptions in the model included the transaction price of the underlying common shares at the transaction date, expected volatility, risk free rate, and certain assumptions around the likelihood, size, and timing of potential future equity raises by Raven. As of March 31, 2022, the period end in which the observable change in price occurred, the Company determined the fair value of the investment in Raven’s common shares and options to be $6.5 million and $8.5 million, respectively.

Additionally, included in Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the nine months ended September 30, 2022 is a $2.4 million impairment loss related to the Company’s investment in Global NRG H2 Limited (“NRG”), a New Zealand corporation, equal to the initial cost basis. In accordance with ASC 321, Investments - Equity Securities (“ASC 321”), the investment in NRG does not have a readily determinable fair value and is measured at cost minus impairment, which requires the Company to evaluate on an ongoing basis whether an investment has been impaired based on qualitative factors. The Company impaired NRG due to the investee’s lack of progress in developing its plans and operating performance. There was no gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended September 30, 2022.

The following table summarizes the total carrying value of held securities, measured as the total initial cost plus cumulative net gain (loss) (in thousands):

	September 30, 2022		December 31, 2021
Total initial cost basis	$	4,948	$	4,948
Adjustments:
Cumulative unrealized gain	12,530		—
Cumulative impairment	(2,448)		—
Carrying amount, end of period	$	15,030	$	4,948

The following table summarizes unrealized gain and impairment recorded in Other income (expense) in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss), which are included as adjustments to the carrying value of equity securities (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Unrealized gain on equity securities	$	—	$	—	$	12,530	$	—
Cumulative impairment	—		—		(2,448)		—
Total unrealized gain and impairment on equity securities	$	—	$	—	$	10,082	$	—

Short-term Investments

The following table summarizes the Company's short-term investments (in thousands):

	As of September 30, 2022
	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Short-term investments
Certificates of deposit	$	105,097	$	175	$	(87)	$	105,186
Commercial paper	47,197		105		—		47,302
Corporate debt securities	39,780		—		(181)		39,598
Foreign government bonds	3,187		—		—		3,187
U.S. Treasury bills	44,287		95		(7)		44,375
Total short-term investments	$	239,548	$	375	$	(275)	$	239,648

The Company did not have any short-term investments as of December 31, 2021.

XML

Short-term Investments

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Short-term Investments

Investments in Equity Securities

The Company owns common shares, participation rights, and options to purchase additional common shares in certain private companies. On a non-recurring basis, the carrying value is adjusted for changes resulting from observable price changes in orderly transactions for identical or similar investments in the same issuer or an impairment.

Included in Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the nine months ended September 30, 2022 is a $12.5 million gain related to the equity investment in Raven SR, Inc. (“Raven”). The investment in Raven’s common shares and options were initially accounted for at cost of $2.5 million. In March 2022, there was an observable change in price of Raven’s common shares. The change in observable price of Raven’s common shares also results in a remeasurement of the investment in Raven’s options as of the date that the observable transaction took place. The fair value of the investment in Raven’s common shares was determined based on observable market prices of identical instruments in less active markets and is classified accordingly as Level 2 in the fair value hierarchy. Due to certain anti-dilution rights included in the options held by the Company, the fair value was determined utilizing a Monte-Carlo simulation model. Accordingly, this was determined to be a Level 3 measurement in the fair value hierarchy. The most significant assumptions in the model included the transaction price of the underlying common shares at the transaction date, expected volatility, risk free rate, and certain assumptions around the likelihood, size, and timing of potential future equity raises by Raven. As of March 31, 2022, the period end in which the observable change in price occurred, the Company determined the fair value of the investment in Raven’s common shares and options to be $6.5 million and $8.5 million, respectively.

Additionally, included in Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the nine months ended September 30, 2022 is a $2.4 million impairment loss related to the Company’s investment in Global NRG H2 Limited (“NRG”), a New Zealand corporation, equal to the initial cost basis. In accordance with ASC 321, Investments - Equity Securities (“ASC 321”), the investment in NRG does not have a readily determinable fair value and is measured at cost minus impairment, which requires the Company to evaluate on an ongoing basis whether an investment has been impaired based on qualitative factors. The Company impaired NRG due to the investee’s lack of progress in developing its plans and operating performance. There was no gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended September 30, 2022.

The following table summarizes the total carrying value of held securities, measured as the total initial cost plus cumulative net gain (loss) (in thousands):

	September 30, 2022		December 31, 2021
Total initial cost basis	$	4,948	$	4,948
Adjustments:
Cumulative unrealized gain	12,530		—
Cumulative impairment	(2,448)		—
Carrying amount, end of period	$	15,030	$	4,948

The following table summarizes unrealized gain and impairment recorded in Other income (expense) in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss), which are included as adjustments to the carrying value of equity securities (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Unrealized gain on equity securities	$	—	$	—	$	12,530	$	—
Cumulative impairment	—		—		(2,448)		—
Total unrealized gain and impairment on equity securities	$	—	$	—	$	10,082	$	—

Short-term Investments

The following table summarizes the Company's short-term investments (in thousands):

	As of September 30, 2022
	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Short-term investments
Certificates of deposit	$	105,097	$	175	$	(87)	$	105,186
Commercial paper	47,197		105		—		47,302
Corporate debt securities	39,780		—		(181)		39,598
Foreign government bonds	3,187		—		—		3,187
U.S. Treasury bills	44,287		95		(7)		44,375
Total short-term investments	$	239,548	$	375	$	(275)	$	239,648

The Company did not have any short-term investments as of December 31, 2021.

XML

Income Taxes

9 Months Ended

Sep. 30, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

For the nine months ended September 30, 2022, the Company recorded a net discrete tax expense of $0.5 million primarily associated with the establishment of a deferred tax liability that is not expected to offset available deferred tax assets. The Company did not record a provision for income taxes for the three months ended September 30, 2022, because the Company generated tax losses. The Company did not record a provision for income taxes for the three and nine months ended September 30, 2021 because the Company generated tax losses.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company assesses all available evidence, both positive and negative, to determine the amount of any required valuation allowance within each taxing jurisdiction. Full valuation allowances have been established for the Company’s operations in all jurisdictions. As of September 30, 2022, and December 31, 2021, the Company had net deferred tax assets of approximately $43.2 million and $23.0 million, respectively, each of which was fully offset by a valuation allowance.

There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its positions. The Company is subject to income tax examinations by taxing authorities in the countries in which it operates since inception.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The Company follows the guidance in ASC 820, Fair Value Measurement. For assets and liabilities measured at fair value on a recurring and nonrecurring basis, a three-level hierarchy of measurements based upon observable and unobservable inputs is used to arrive at fair value. The Company uses valuation approaches that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

•Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

•Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

•Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.

As of September 30, 2022, and December 31, 2021, the carrying amount of accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate estimated fair value due to their relatively short maturities.

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands):

	As of September 30, 2022
	Level 1		Level 2		Level 3		Total
Assets:
Cash equivalents:	$	16,330	$	24,283	$	—	$	40,613
Short-term investments:
Certificates of deposit	—		105,186		—		105,186
Commercial paper	—		47,302		—		47,302
Corporate debt securities	—		39,598		—		39,598
Foreign government bonds	—		3,187		—		3,187
U.S. Treasury bill	44,375		—		—		44,375
Liabilities:
Warrant liability – Private Placement Warrants	$	—	$	1,843	$	—	$	1,843
Earnout shares liability	—		—		16,390		16,390

	As of December 31, 2021
	Level 1		Level 2		Level 3		Total
Liabilities:
Warrant liability – Private Placement Warrants	$	—	$	15,228	$	—	$	15,228
Earnout shares liability	—		—		103,761		103,761

Cash Equivalents

The Company’s cash equivalents consist of short-term, highly liquid financial instruments that are readily convertible to cash with original maturities of three months or less. As of September 30, 2022, the Company has $40.6 million invested in commercial paper, certificates of deposit and money market funds. The Company classifies its investments in commercial paper and certificates of deposit as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

Short-term Investments

The Company’s short-term investments consist of high-quality, investment-grade marketable debt securities and are classified as available-for-sale. The Company classifies its investments in certificates of deposit, commercial paper, corporate debt securities, and foreign government bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

Earnout to Common Stockholders

The fair value of the earnout shares was estimated by utilizing a Monte-Carlo simulation model. The inputs into the Monte-Carlo pricing model included significant unobservable inputs. The following table provides quantitative information regarding Level 3 fair value measurement inputs:

	September 30, 2022			December 31, 2021
Stock price	$	1.70		$	6.49
Risk-free interest rate	4.2		%	1.2		%
Volatility	98.0		%	90.0		%
Remaining term (in years)	3.79			4.54

The following table presents the changes in the liabilities for Private Placement Warrants and Earnout for the nine months ended September 30, 2022 (in thousands):

	Private Placement Warrants		Earnout
Balance as of December 31, 2021	$	15,228	$	103,761
Change in estimated fair value	(13,385)		(87,371)
Balance as of September 30, 2022	$	1,843	$	16,390

The Company performs routine procedures such as comparing prices obtained from independent sources to ensure that appropriate fair values are recorded.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Legal Proceedings

The Company is subject to, and may become a party to, a variety of litigation, other claims, suits, indemnity demands, regulatory actions, and government investigations and inquiries in the ordinary course of business. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain. The Company accrues for matters when we believe that losses are probable and can be reasonably estimated. As of September 30, 2022, the Company accrued $2.4 million in Accrued liabilities in the unaudited interim Consolidated Balance Sheets. The Company did not record any accruals as of December 31, 2021.

As the outcome of individual matters is not predictable with assurance, the assessments are based on the Company’s knowledge and information available at the time; thus, the ultimate outcome of any matter could require payment substantially in excess of the amount being accrued and/or disclosed. The Company is party to current legal proceedings as discussed more fully below.

Shareholder Securities and Derivative Litigation

Three related putative securities class action lawsuits were filed between September 30, 2021 and November 15, 2021, in the U.S. District Court for the Western District of New York against the Company, certain of the Company’s current and former officers and directors and certain former officers and directors of DCRB (Kauffmann v. Hyzon Motors Inc., et al. (No. 21- cv-06612-CJS), Brennan v. Hyzon Motors Inc., et al. (No. 21-cv-06636-CJS), and Miller v. Hyzon Motors Inc. et al. (No. 21-cv-06695-CJS)), asserting violations of federal securities laws. The complaints generally allege that the Company and individual defendants made materially false and misleading statements relating to the nature of the Company’s customer contracts, vehicle orders, and sales and earnings projections, based on allegations in a report released on September 28, 2021, by Blue Orca Capital, an investment firm that indicated that it held a short position in the Company’s stock and which has made numerous allegations about the Company. These lawsuits have been consolidated under the caption In re Hyzon Motors Inc. Securities Litigation (Case No. 6:21-cv-06612-CJS-MWP), and on March 21, 2022, the court-appointed lead plaintiff filed a consolidated amended complaint seeking monetary damages. The Company and individual defendants moved to dismiss the consolidated amended complaint on May 20, 2022, and the court-appointed lead plaintiff filed its opposition to the motion on July 19, 2022. The court-appointed lead plaintiff filed an amended complaint on March 21, 2022, and a second amended complaint on September 16, 2022. Briefing regarding the Company and individual defendants’ anticipated motion to dismiss the second amended complaint has been stayed pending a scheduled, non-binding mediation among the parties. There is no assurance that the mediation will proceed as scheduled, or that, if mediation occurs, any or all parties will reach a settlement.

Between December 16, 2021, and January 14, 2022, three related shareholder derivative lawsuits were filed in the U.S. District Court for the Western District of New York (Lee v. Anderson et al. (No. 21-cv-06744-CJS), Révész v. Anderson et al. (No. 22-cv-06012-CJS), and Shorab v. Anderson et al. (No. 22-cv-06023-CJS)). These three lawsuits have been consolidated under the caption In re Hyzon Motors Inc. Derivative Litigation (Case No. 6:21-cv-06744-CJS). On February 2, 2022, a similar shareholder derivative lawsuit was filed in the U.S. District Court for the District of Delaware (Yellets v. Gu et al. (No. 22-cv-00156)). On February 3, 2022, a similar shareholder derivative lawsuit was filed in the Supreme Court of the State of New York, Kings County (Ruddiman v. Anderson et al. (No. 503402/2022)). On February 13, 2023, a similar shareholder derivative lawsuit was filed in the Delaware Court of Chancery (Kelley v. Knight et al. (C.A. No. 2023-0173)). These lawsuits name as defendants the Company’s current and former directors and certain former directors of DCRB, along with the Company as a nominal defendant, and generally allege that the individual defendants breached their fiduciary duties by making or failing to prevent the misrepresentations alleged in the consolidated securities class action, and assert claims for violations of federal securities laws, breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and/or waste of corporate assets. These lawsuits generally seek equitable relief and monetary damages. With the exception of the recently filed action in the Delaware Court of Chancery, each of the shareholder derivative actions has been stayed or the parties have jointly requested that it be stayed pending a decision regarding the anticipated motion to dismiss in the consolidated securities class action.

On March 18, 2022, a putative class action complaint, Malork v. Anderson et al. (C.A. No. 2022-0260- KSJM), was filed in the Delaware Court of Chancery against certain officers and directors of DCRB, DCRB’s sponsor, and certain investors in DCRB’s sponsor, alleging that the director defendants and controlling shareholders of DCRB’s sponsor breached their fiduciary duties in connection with the merger between DCRB and Legacy Hyzon. The complaint seeks equitable relief and monetary damages. On May 26, 2022, the defendants in this case moved to dismiss the complaint. On August 2, 2022, the plaintiff filed an amended complaint. Defendants filed a motion to dismiss the amended complaint on August 15, 2022.

Between January 26, 2022 and August 22, 2022, Hyzon received demands for books and records pursuant to Section 220 of the Delaware General Corporation Law from four stockholders who state they are investigating whether to file similar derivative or stockholder lawsuits, among other purposes. On May 31, 2022, one of these four stockholders represented that he had concluded his investigation and did not intend to file a complaint. On November 18, 2022, a second of the four stockholders filed a lawsuit in the Delaware Court of Chancery (Abu Ghazaleh v. Decarbonization Plus Acquisition Sponsor, LLC et al. (C.A. No. 2022-1050)), which was voluntarily dismissed shortly thereafter on December 1, 2022. On February 13, 2023, a third of these four shareholders filed a derivative lawsuit in the Delaware Court of Chancery (Kelley v. Knight et al. (C.A. No. 2023-0173)). The complaint asserts claims for breach of fiduciary duty and generally alleges that the individual defendants breached their fiduciary duties by making or failing to prevent misrepresentations including those alleged in the consolidated securities class action and the report released by Blue Orca Capital. As with the previously filed shareholder derivative lawsuits, the complaint seeks equitable relief and monetary damages.

On April 18, 2023, the Company received a demand for books and records pursuant to Section 220 of the Delaware General Corporation Law from a stockholder seeking to investigate possible breaches of fiduciary duty or other misconduct or wrongdoing by the Company's controlling stockholder, Hymas Pte. Ltd. ("Hymas"), Hyzon's board of directors (the "Board") and/or certain members of Hyzon's senior management team in connection with the Company's entrance into (i) an equity transfer agreement (the "Equity Transfer") with certain entities affiliated with the Company, and (ii) the share buyback agreement with the Hymas (the "Share Buyback" and, together with the Equity Transfer, the "Transactions") as reported by the Company in its Form 8-K filed on December 28, 2022.

The above proceedings are subject to uncertainties inherent in the litigation process. The Company cannot predict the outcome of these matters or estimate the possible loss or range of possible loss, if any at this time.

Government Investigations

On January 12, 2022, the Company received a subpoena from the SEC for production of documents and information, including documents and information related to the allegations made in the September 28, 2021 report issued by Blue Orca Capital. The Company received two additional subpoenas in connection with the SEC’s investigation on August 5, 2022 and August 10, 2022. On October 31, 2022, the U.S. Attorney’s Office for the Southern District of New York (“SDNY”) notified the Company that it is also investigating these matters. The Company is cooperating and will continue to cooperate with these and any other regulatory or governmental investigations or inquiries. The Company cannot predict the ultimate outcome of the SEC and the SDNY investigations or inquiries. It is not possible to accurately predict at this time when matters will be completed, the final outcome as a result of those investigations or inquiries, what if any actions may be taken by the SEC or the SDNY, or the effect that such actions may have on our business, prospects, operating results and financial condition, which could be material.

Customer and Supplier Dispute

From time to time, the Company is subject to various commercial disputes or claims with its customers or suppliers. In January 2023, Duurzaam Transport B.V. and H2 Transport B.V., both private limited companies in the Netherlands and customers of the Company’s European subsidiary, Hyzon Motors Europe B.V. (“Hyzon Europe”), filed an attachment with the local Dutch court. The initial attachment claimed that Hyzon Europe was liable for liquidated and consequential damages stemming from Hyzon Europe allegedly not delivering trucks as contracted. The initial attachment placed a lien on the assets of Hyzon Europe. Following the attachments, Duurzaam Transport B.V. and H2 Transport B.V. initiated proceedings on the merits in February 2023. Eventually, the dispute was settled without any party admitting liability, and the Company made a payment of €2.1 million (approximately $2.0 million in USD) in April 2023, which was recorded in Accrued liabilities in the unaudited interim Consolidated Balance Sheets as of September 30, 2022.

Regardless of outcome, such proceedings or claims can have an adverse impact on the Company because of legal defense and settlement costs, the Company’s obligations to indemnify third parties, diversion of resources, and other factors, and there can be no assurances that favorable outcomes will be obtained. Based on the early-stage nature of these cases, the Company cannot predict the outcome of these currently outstanding customer and supplier dispute matters or estimate the possible loss or range of possible loss, if any.

XML

Stock-based Compensation Plans

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

Stock-based Compensation Plans

Stock-based Compensation Plans

The following table summarizes the Company’s stock option and Restricted Stock Unit (“RSU”) activity:

	Stock Options					RSUs
	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual (Years)	Aggregate Intrinsic Value (in 000s)	Number of RSUs	Weighted Average Grant Date Fair Value
Outstanding at December 31, 2021	19,311,140	$	1.29	13.07	100,885	1,852,685	$	6.14
Granted	539,292	$	4.64	—	—	1,260,408	$	3.72
Exercised or released	(38,868)	$	1.13	—	—	(468,778)	$	6.79
Forfeited/Cancelled	(83,284)	$	1.13	—	—	(106,128)	$	5.15
Outstanding at September 30, 2022	19,728,280	$	1.51	12.17	8,054	2,538,187	$	4.86
Vested and expected to vest, September 30, 2022	14,190,780	$	1.21	11.74	8,054	2,538,187	$	4.86
Exercisable and vested at September 30, 2022	12,410,743	$	1.13	12.54	7,091	—

As of September 30, 2022, there was $2.7 million of unrecognized stock-based compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 3.5 years.

RSUs granted under the Company’s equity incentive plans typically vest over a four or five-year period beginning on the date of grant. RSUs will be settled through the issuance of an equivalent number of shares of the Company’s common stock and are equity classified. The fair value of restricted shares is determined based upon the stock price on the date of grant. As of September 30, 2022, unrecognized compensation costs related to unvested RSUs of $11.1 million is expected to be recognized over a remaining weighted average period of 3.09 years.

Earnout to Other Equity Holders

Earnout awards to other equity holders accounted for under ASC 718, Compensation - Stock Compensation (“ASC 718”) were vested at the time of grant, and therefore recognized immediately as compensation expense. Total compensation expense/(benefit) recorded for the three and nine months ended September 30, 2022 related to these earnout awards was $(0.1) million and $0.8 million, respectively. Total compensation expense recorded for the three and nine months ended September 30, 2021 related to these earnout awards was $14.0 million. Certain earnout awards to other equity holders contained performance and market-based vesting conditions, and as the performance conditions are not deemed probable at September 30, 2022, no compensation expense has been recorded related to these awards.

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Stockholders' Equity

Stockholders' Equity

Common Stock

The Company is authorized to issue 400,000,000 shares of common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At September 30, 2022 and December 31, 2021, there were 248,153,362 and 247,758,412 shares of Class A common stock issued and outstanding, respectively.

Warrants

At September 30, 2022, there were 11,013,665 Public Warrants and 8,014,500 Private Placement Warrants, for a total of 19,028,165 warrants outstanding. At December 31, 2021, there were 11,286,242 Public Warrants and 8,014,500 Private Placement Warrants, for a total of 19,300,742 warrants outstanding. At September 30, 2022, and December 31, 2021, there were 170,048 and 275,048 Ardour Warrants outstanding, respectively.

Equity Repurchase Program

On November 17, 2021, the Company’s board of directors authorized the repurchase of up to $5.0 million of its outstanding common stock and/or Public Warrants. The timing and amount of any share repurchases under the Company’s share repurchase authorization will be determined by management based on market conditions and other considerations. Such repurchases may be executed in the open market. As of December 31, 2021, the Company had repurchased 256,977 public warrants for $0.5 million. In the nine months ended September 30, 2022, the Company repurchased an additional 15,600 public warrants for $31 thousand. The Company repurchased a total of 272,577 public warrants and suspended the share repurchase program as of January 5, 2022.

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2022

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

Horizon IP Agreement

In January 2021, the Company entered into an intellectual property agreement (the “Horizon IP Agreement”) with Jiangsu Qingneng New Energy Technologies Co., Ltd. and Shanghai Qingneng Horizon New Energy Ltd. (together, “JS Horizon”) both of which are subsidiaries of the Company’s ultimate parent, Horizon. In September 2021, Jiangsu Horizon Powertrain Technologies Co. Ltd. (“JS Powertrain”) was an added party to the agreement. Pursuant to the agreement the parties convey to each other certain rights in intellectual property relating to Hyzon’s core fuel cell and mobility product technologies, under which Hyzon was to pay JS Horizon and JS Powertrain a total fixed payment of $10.0 million. The full $10.0 million has been paid, $6.9 million was paid in 2021 and the remaining $3.1 million was paid in February 2022.

Related Party Payables and Receivables

Horizon Fuel Cell Technologies and Related Subsidiaries

The Company made deposit payments to Horizon and its subsidiaries to secure certain fuel cell components. As of September 30, 2022, the remaining balance is $6.0 million and included within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance Sheets.

Certain employees of Horizon and its subsidiaries provide research and development, staff training, and administrative services to the Company. Based on an analysis of the compensation costs incurred by Horizon and an estimate of the proportion of effort spent by such employees on each entity, an allocation of approximately $0.4 million and $1.2 million was recorded in the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the three months ended September 30, 2022, and 2021, respectively. An allocation of approximately $0.9 million and $1.8 million was recorded in the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the nine months ended September 30, 2022, and 2021, respectively.

The related party payable to Horizon and its subsidiaries is $0.1 million and $3.7 million as of September 30, 2022 and December 31, 2021, respectively.

Holthausen and Affiliates

The Company entered into a joint venture agreement in October 2020 to create Hyzon Europe with Holthausen Clean Technology Investments B.V. (“Holthausen”). As Hyzon Europe builds out its production facilities, it relies on Holthausen and its affiliates for certain production resources that result in related party transactions. In addition, both companies rely on certain suppliers, including Horizon.

The Company currently owns 50.5% of the equity interests of Hyzon Europe. On December 31, 2021, Hyzon executed a non-binding Letter of Intent (“LOI”) with Holthausen to increase its stake to 75% in Hyzon Europe. Concurrent with the signing of this LOI, a €1 million refundable deposit was paid to Holthausen, approximately $1.1 million in U.S. dollars (“USD”). This deposit is recorded within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance Sheets.

Subsequently, in December 2022, the Company acquired the remaining 49.5% of the equity interests of Hyzon Europe from Holthausen. The Company now holds 100% ownership in Hyzon Europe. The Company paid €3.5 million (approximately $3.7 million in USD) in addition to €1.0 million (approximately $1.1 million in USD) paid in December 2021. As part of this transaction, the Company also transferred various inventory items to, and settled open related party balances with, Holthausen. In addition, the Company reassigned all of the assumed retrofit service contracts, including after-sales obligations, back to Holthausen Clean Technology B.V.

For the three and nine months ended September 30, 2022, the Company paid $0.1 million and $0.4 million, respectively, to Carl Holthausen and Max Holthausen as managing directors of Hyzon Europe. For the three and nine months ended September 30, 2021, the Company paid $0.1 million and $0.3 million, respectively.

As of September 30, 2022, the related party payable to Holthausen is $0.3 million. As of December 31, 2021, the related party receivable from Holthausen is $0.3 million.

Jiushuang Joint Ventures

As described in Note 3. Revenue, the Company delivered 20 FCEVs to Jiushuang (Shanghai) New Energy Technology Co., Ltd. during the three months ended September 30, 2022. Jiushuang (Shanghai) New Energy Technology Co., Ltd. is a parent of both Jiushuang Tiancheng Motors Service Ltd. (“JSTC”) and Jiushuang Suda Logistics Ltd. (“JSSD”), which the Company partnered with to form the Jiushuang joint ventures.

XML

Income (Loss) per share

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Income (Loss) per share

Income (Loss) per share

Basic net income (loss) per share is computed by dividing net income attributable to shareholders of Hyzon by the weighted-average number of common shares outstanding during the reporting period. Diluted net income per share is computed similarly to basic net income per share, except that it includes the potential dilution that could occur if dilutive securities were exercised.

The following table presents the information used in the calculation of the Company’s basic and diluted net income (loss) per share attributable to Hyzon common stockholders (in thousands, except per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income (loss) attributable to Hyzon	$	(24,795)	$	34,621	$	10,681	$	17,053
Weighted average shares outstanding:
Basic	248,164		234,091		248,054		189,101
Effect of dilutive securities	—		12,389		9,774		11,883
Diluted	248,164		246,480		257,828		200,984
Net income (loss) per share attributable to Hyzon:
Basic	$	(0.10)	$	0.15	$	0.04	$	0.09
Diluted	$	(0.10)	$	0.14	$	0.04	$	0.08

The weighted average number of shares outstanding prior to Business Combination were converted at the Exchange Ratio.

Potentially dilutive shares are excluded from the computation of diluted net income (loss) per share when their effect was antidilutive. The potential dilutive securities are summarized as follows (in thousands):

	Three Months Ended September 30,		Nine Months Ended September 30,
	2022	2021	2022	2021
Restricted stock units	2,538	426	937	426
Stock options with service conditions	12,419	—	539	—
Stock options for former CTO	1,772	—	—	—
Stock options with market and performance conditions	5,538	5,538	5,538	5,538
Private placement warrants	8,015	8,015	8,015	8,015
Public warrants	11,014	11,286	11,014	11,286
Earnout shares	23,250	23,250	23,250	23,250
Hongyun warrants	31	—	31	—
Ardour warrants	170	326	—	326

XML

Subsequent events

9 Months Ended

Sep. 30, 2022

Subsequent Events [Abstract]

Subsequent events

Subsequent Events

Raven SR S1 LLC

In December 2022, the Company entered into an agreement with Chevron New Energies and Raven, to invest in Raven SR S1 LLC. Raven SR S1 LLC intends to develop, construct, operate and maintain a solid waste-to hydrogen generation production facility located in Richmond, California. The Company invested $8.5 million at closing, and the remaining $1.5 million will be paid in 2023 for an approximate 20% ownership in Raven SR S1 LLC. The Company accounted for the agreement as an equity method investment with a cost basis determined by the funding date capital contribution. The subsequent payment will add to the overall cost basis of the investment when paid.

Divestiture of Hyzon Guangdong

In December 2022, the Company sold all of its equity interest in Hyzon Motors Technology (Guangdong) Co., Ltd. (“Hyzon Guangdong”) to Hymas for approximately $3.1 million in cash, subject to certain adjustments. As a common control transaction, the difference of $0.5 million between the consideration received and the book value is expected to be recognized in the Company’s additional paid-in-capital during the three months ended December 31, 2022. Subsequent to the divestiture, Hyzon Guangdong changed its name to Guangdong Qingyun Technology Co. Ltd. (“Guangdong Qingyun”).

Additionally, together with the execution of the Hyzon Guangdong divestiture, the Company entered into a share buyback agreement and repurchased approximately 3.8 million shares of common stock from Hymas in exchange for approximately $6.4 million in cash.

In April 2023, Guangdong Qingyun paid $3.3 million to the Company to settle intercompany balances and Hymas paid the Company $3.1 million related to the Hyzon Guangdong divestiture.

Nasdaq Deficiency Notice

In February 2023, the Company received a Staff Determination from the Listing Qualifications Staff of Nasdaq notifying the Company that unless the Company requests an appeal, trading of the Company's Class A common stock and warrants will be suspended from The Nasdaq Capital Market at the opening of business on February 14, 2023, and a Form 25-NSE will be filed with the SEC. On February 10, 2023, the Hearings Panel granted the Company a 15 calendar day stay of delisting, and will notify the Company within this 15 calendar day period whether the Company’s request for a stay pending the hearing will be granted. The date for the delisting hearing was March 16, 2023. At the hearing, the Company presented its plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) and requested the continued listing of its securities on The Nasdaq Capital Market pending such compliance. In March 2023, the Company received a letter from the Hearings Panel indicating that the Hearings Panel granted the Company’s request for continued listing until May 15, 2023, in order to allow the Company to regain compliance with the periodic filing rule.

On April 6, 2023, the Company received an additional Staff Determination (the “Additional Staff Determination”) from the Staff notifying the Company that, because the Staff did not receive the Company’s Form 10-K for the year ended December 31, 2022, the Company does not comply with Nasdaq’s Listing Rules for continued listing, thus constituting an additional basis for delisting the Company’s securities from The Nasdaq Capital Market. The Additional Staff Determination further notified the Company that the Hearings Panel will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market, and that the Company should present its views with respect to this additional deficiency to the Hearings Panel in writing no later than April 13, 2023. On April 13, 2023, the Company filed its response to the Additional Staff Determination.

Delaware Court of Chancery Section 205

On February 13, 2023, the Company filed a petition under the caption In re Hyzon Motors Inc., C.A. No. 2023-0177-LWW (Del. Ch) in the Delaware Court of Chancery pursuant to Section 205 of the Delaware General Corporation Law (“DGCL”), which permits the Court of Chancery, in its discretion, to validate potentially defective corporate acts due to developments regarding potential interpretations of the DGCL stemming from the Court’s recent decision in Garfield v. Boxed, Inc., 2022 WL 17959766 (Del. Ch. Dec. 27, 2022). On March 6, 2023, the Court of Chancery granted our petition, holding that any defects that may have existed with respect to the conduct of the Special Meeting of Shareholders held on July 15, 2021 to approve the increase in the Company’s authorized share capital were ratified as of the meeting.

The Company continues to believe that, notwithstanding the relief the Delaware Court of Chancery granted to the Company under Section 205, at the time of DCRB Shareholder Meeting on July 16, 2021, the increase in the Company’s authorized share capital was validly approved by DCRB’s shareholders under Delaware law.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Basis of Presentation

The accompanying unaudited interim consolidated financial statements and related disclosures have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the requirements and rules of the SEC regarding interim reporting. Certain notes or other information that are normally required by U.S. GAAP have been omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited interim consolidated financial statements should be read in connection with the Company’s audited consolidated financial statements and related notes included in the Company’s amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021. The Company’s unaudited interim consolidated financial statements include the accounts and operations of the Company and its wholly owned subsidiaries including variable interest entity arrangements in which the Company is the primary beneficiary. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited interim consolidated financial statements include all normal and recurring adjustments necessary for a fair presentation for the periods presented. Results of operations reported for interim periods presented are not necessarily indicative of results for the entire year or any other periods.

Cash Equivalents

Cash Equivalents The Company’s cash equivalents consist of short-term, highly liquid financial instruments that are readily convertible to cash with original maturities of three months or less. Due to their short-term nature, the amortized cost of the Company’s cash equivalents approximate fair value. As of September 30, 2022, cash equivalents consisted of commercial paper, certificates of deposit and money market funds

Short-term Investments

Short-term Investments

The Company has short-term investments in marketable debt securities with an original maturity of greater than three months, but less than one year. These securities include certificates of deposit, commercial paper, corporate debt, foreign government bonds, and U.S. Treasury bills. The Company may sell these marketable debt securities prior to their stated maturities depending upon changing liquidity requirements. The Company’s marketable debt securities have been classified and accounted for as available-for-sale (“AFS”) marketable securities in accordance with ASC 326, Financial Instruments - Credit Losses. AFS securities are recorded at fair value as of each balance sheet date, with unrealized gains or losses included in Accumulated other comprehensive income (loss) and as a component of the Consolidated Statements of Operations and Comprehensive Income (Loss). Gains and losses as a result of sales or maturity of securities are reclassified from previously unrealized gains and losses on short-term investments in Accumulated other comprehensive income (loss) to Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Income (Loss).

For an AFS security with an amortized cost that exceeds its fair value, the Company first determines if it intends to sell or will more-likely-than-not be required to sell the security before the expected recovery of its amortized cost. If it intends to sell or will more-likely-than-not be required to sell the security, then the Company recognizes the impairment as a credit loss in the Consolidated Statements of Operations and Comprehensive Income (Loss) by writing down the security’s amortized cost to its fair value. If it does not intend to sell or it is not more-likely-than-not that it will be required to sell the security before the expected recovery of its amortized cost, the Company recognizes the portion of the impairment that is due to a credit loss, if any, in the Consolidated Statements of Operations and Comprehensive Income (Loss) through an allowance. The portion of the impairment that is due to factors other than a credit loss is recognized in Comprehensive income (loss) in the Consolidated Statements of Operations and Comprehensive Income (Loss) as an unrealized loss. Accrued interest receivable is excluded from the estimate of credit losses

XML

Inventory (Tables)

9 Months Ended

Sep. 30, 2022

Inventory Disclosure [Abstract]

Schedule of inventory

Inventory consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Raw materials	$	26,434	$	16,099
Work in process	13,391		4,828
Total inventory	$	39,825	$	20,927

XML

Prepaid Expenses and Other Current Assets (Tables)

9 Months Ended

Sep. 30, 2022

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of prepaid expenses and other current assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Deposit for fuel cell components (Note 15)	$	6,017	$	5,008
Vehicle inventory deposits	6,638		10,171
Production equipment deposits	242		1,169
Other prepaid expenses	4,673		3,266
Prepaid insurance	4,345		5,079
VAT receivable from government	2,155		2,159
Total prepaid expenses and other current assets	$	24,070	$	26,852

XML

Property, Plant, and Equipment, net (Tables)

9 Months Ended

Sep. 30, 2022

Property, Plant and Equipment [Abstract]

Schedule of property, plant and equipment

Property, plant, and equipment, net consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Land and building	$	2,818	$	2,818
Machinery and equipment	16,197		8,827
Software	2,071		507
Leasehold improvements	1,356		746
Construction in progress	5,081		2,139
Total Property, plant, and equipment	27,523		15,037
Less: Accumulated depreciation and amortization	(2,654)		(691)
Property, plant and equipment, net	$	24,869	$	14,346

XML

Accrued liabilities (Tables)

9 Months Ended

Sep. 30, 2022

Payables and Accruals [Abstract]

Schedule of accrued liabilities

Accrued liabilities consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Payroll and payroll related expenses	$	3,904	$	2,250
Accrued professional fees	5,325		2,450
Accrued product warranty costs	903		816
Accrued contract manufacturer costs	1,346		—
Accrued contract termination costs (Note 12)	2,430		—
Accrued Orten cancellation costs (Note 1)	1,617		—
Accrued severance	475		—
Other accrued expenses	2,586		1,254
Accrued liabilities	$	18,586	$	6,770

XML

Investments in Equity Securities (Tables)

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Summary of equity securities

The following table summarizes the total carrying value of held securities, measured as the total initial cost plus cumulative net gain (loss) (in thousands):

	September 30, 2022		December 31, 2021
Total initial cost basis	$	4,948	$	4,948
Adjustments:
Cumulative unrealized gain	12,530		—
Cumulative impairment	(2,448)		—
Carrying amount, end of period	$	15,030	$	4,948

The following table summarizes unrealized gain and impairment recorded in Other income (expense) in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss), which are included as adjustments to the carrying value of equity securities (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Unrealized gain on equity securities	$	—	$	—	$	12,530	$	—
Cumulative impairment	—		—		(2,448)		—
Total unrealized gain and impairment on equity securities	$	—	$	—	$	10,082	$	—

XML

Short-term Investments (Tables)

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Schedule of short-term investments

The following table summarizes the Company's short-term investments (in thousands):

	As of September 30, 2022
	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
Short-term investments
Certificates of deposit	$	105,097	$	175	$	(87)	$	105,186
Commercial paper	47,197		105		—		47,302
Corporate debt securities	39,780		—		(181)		39,598
Foreign government bonds	3,187		—		—		3,187
U.S. Treasury bills	44,287		95		(7)		44,375
Total short-term investments	$	239,548	$	375	$	(275)	$	239,648

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Summary of assets and liabilities that are measured at fair value on a recurring basis

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands):

	As of September 30, 2022
	Level 1		Level 2		Level 3		Total
Assets:
Cash equivalents:	$	16,330	$	24,283	$	—	$	40,613
Short-term investments:
Certificates of deposit	—		105,186		—		105,186
Commercial paper	—		47,302		—		47,302
Corporate debt securities	—		39,598		—		39,598
Foreign government bonds	—		3,187		—		3,187
U.S. Treasury bill	44,375		—		—		44,375
Liabilities:
Warrant liability – Private Placement Warrants	$	—	$	1,843	$	—	$	1,843
Earnout shares liability	—		—		16,390		16,390

	As of December 31, 2021
	Level 1		Level 2		Level 3		Total
Liabilities:
Warrant liability – Private Placement Warrants	$	—	$	15,228	$	—	$	15,228
Earnout shares liability	—		—		103,761		103,761

Summary of quantitative information regarding Level 3 fair value measurement inputs

The following table provides quantitative information regarding Level 3 fair value measurement inputs:

	September 30, 2022			December 31, 2021
Stock price	$	1.70		$	6.49
Risk-free interest rate	4.2		%	1.2		%
Volatility	98.0		%	90.0		%
Remaining term (in years)	3.79			4.54

Summary of the changes in the liability for Private Placement warrants and Earnout

The following table presents the changes in the liabilities for Private Placement Warrants and Earnout for the nine months ended September 30, 2022 (in thousands):

	Private Placement Warrants		Earnout
Balance as of December 31, 2021	$	15,228	$	103,761
Change in estimated fair value	(13,385)		(87,371)
Balance as of September 30, 2022	$	1,843	$	16,390

XML

Stock-based Compensation Plans (Tables)

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of stock option and RSU activity

The following table summarizes the Company’s stock option and Restricted Stock Unit (“RSU”) activity:

	Stock Options					RSUs
	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual (Years)	Aggregate Intrinsic Value (in 000s)	Number of RSUs	Weighted Average Grant Date Fair Value
Outstanding at December 31, 2021	19,311,140	$	1.29	13.07	100,885	1,852,685	$	6.14
Granted	539,292	$	4.64	—	—	1,260,408	$	3.72
Exercised or released	(38,868)	$	1.13	—	—	(468,778)	$	6.79
Forfeited/Cancelled	(83,284)	$	1.13	—	—	(106,128)	$	5.15
Outstanding at September 30, 2022	19,728,280	$	1.51	12.17	8,054	2,538,187	$	4.86
Vested and expected to vest, September 30, 2022	14,190,780	$	1.21	11.74	8,054	2,538,187	$	4.86
Exercisable and vested at September 30, 2022	12,410,743	$	1.13	12.54	7,091	—

XML

Income (Loss) per share (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Schedule of earnings per share, basic and diluted

The following table presents the information used in the calculation of the Company’s basic and diluted net income (loss) per share attributable to Hyzon common stockholders (in thousands, except per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net income (loss) attributable to Hyzon	$	(24,795)	$	34,621	$	10,681	$	17,053
Weighted average shares outstanding:
Basic	248,164		234,091		248,054		189,101
Effect of dilutive securities	—		12,389		9,774		11,883
Diluted	248,164		246,480		257,828		200,984
Net income (loss) per share attributable to Hyzon:
Basic	$	(0.10)	$	0.15	$	0.04	$	0.09
Diluted	$	(0.10)	$	0.14	$	0.04	$	0.08

Schedule of antidilutive securities excluded from computation of earnings per share

	Three Months Ended September 30,		Nine Months Ended September 30,
	2022	2021	2022	2021
Restricted stock units	2,538	426	937	426
Stock options with service conditions	12,419	—	539	—
Stock options for former CTO	1,772	—	—	—
Stock options with market and performance conditions	5,538	5,538	5,538	5,538
Private placement warrants	8,015	8,015	8,015	8,015
Public warrants	11,014	11,286	11,014	11,286
Earnout shares	23,250	23,250	23,250	23,250
Hongyun warrants	31	—	31	—
Ardour warrants	170	326	—	326

XML

Nature of Business and Basis of Presentation (Detail) $ / shares in Units, $ in Thousands, € in Millions		1 Months Ended		3 Months Ended		9 Months Ended
	Jul. 16, 2021 USD ($) $ / shares	Sep. 30, 2022 USD ($) $ / shares	Sep. 30, 2022 EUR (€)	Sep. 30, 2022 USD ($) $ / shares	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) $ / shares	Sep. 30, 2021 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2021 USD ($) $ / shares
Business Combination, Separately Recognized Transactions [Line Items]
Common stock, par value (dollars per share) | $ / shares	$ 0.0001	$ 0.0001		$ 0.0001		$ 0.0001			$ 0.0001
Net income (loss)				$ (35,653)	$ 33,845	$ (5,680)	$ 15,746
Accumulated deficit		$ (15,731)		(15,731)		(15,731)			$ (26,412)
Cash flows used in operating activities						(116,218)	$ (52,242)
Unrestricted cash		70,600		70,600		70,600
Restricted cash		7,000		7,000		7,000
Cash invested in money market funds		70,602		70,602		70,602			445,146
Fair Value		$ 239,648		$ 239,648		$ 239,648			$ 0
Subsequent Event
Business Combination, Separately Recognized Transactions [Line Items]
Unrestricted cash, cash equivalents, and short-term investments								$ 210,000
Legacy Hyzon
Business Combination, Separately Recognized Transactions [Line Items]
Cash received in transaction net of redemption and transaction costs	$ 509,000
Legacy Hyzon | Common Stock Class A
Business Combination, Separately Recognized Transactions [Line Items]
Stockholders equity note, stock split, conversion ratio (in shares)	1.772
Orten Holding GmbH
Business Combination, Separately Recognized Transactions [Line Items]
Percent of voting interests expected to be purchased		100.00%		100.00%		100.00%
Loss on contract termination		$ 8,400	€ 8.5
Contract termination fee paid in cash		6,100	6.1
Equipment transferred in payment on contract termination fee		$ 2,300	€ 2.4

XML

Summary of Significant Accounting Policies (Detail) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Cash equivalents:	$ 40,600,000	$ 0

XML

Revenue (Detail) $ in Millions	3 Months Ended			9 Months Ended		12 Months Ended
	Dec. 31, 2022 USD ($)	Sep. 30, 2022 USD ($) vehicle	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) vehicle
Disaggregation of Revenue [Line Items]
Number of vehicles | vehicle		20				62
Revenue recognized				$ 0.0
Contract liabilities		$ 0.8		0.8		$ 10.9
Long term portion of customer liabilities		5.6		5.6		$ 1.0
Remaining performance obligations		$ 15.4		$ 15.4
Subsequent Event
Disaggregation of Revenue [Line Items]
Refunds to customer	$ 0.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Disaggregation of Revenue [Line Items]
Percentage of performance obligations recognized as revenue		5.00%		5.00%
Timing of performance obligations recognized as revenue		12 months		12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Disaggregation of Revenue [Line Items]
Percentage of performance obligations recognized as revenue		41.00%		41.00%
Timing of performance obligations recognized as revenue
Certain Customers In China | Australia Regions
Disaggregation of Revenue [Line Items]
Revenue recognized				$ 2.5
Fuel
Disaggregation of Revenue [Line Items]
Revenue from contract with customer		$ 2.9	$ 0.1	2.9	$ 0.1
FCEVs
Disaggregation of Revenue [Line Items]
Cost of vehicles delivered				$ 2.9

XML

Inventory (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 26,434	$ 26,434	$ 16,099
Work in process	13,391	13,391	4,828
Inventory	39,825	39,825	$ 20,927
Inventory write-down	$ 2,300	$ 3,000

XML

Prepaid Expenses and Other Current Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Deposit for fuel cell components (Note 15)	$ 6,017	$ 5,008
Vehicle inventory deposits	6,638	10,171
Production equipment deposits	242	1,169
Other prepaid expenses	4,673	3,266
Prepaid insurance	4,345	5,079
VAT receivable from government	2,155	2,159
Total prepaid expenses and other current assets	$ 24,070	$ 26,852

XML

Property, Plant, and Equipment, net - Schedule of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property plant equipment gross	$ 27,523	$ 15,037
Less: Accumulated depreciation and amortization	(2,654)	(691)
Property, plant and equipment, net	24,869	14,346
Land and building
Property, Plant and Equipment [Line Items]
Property plant equipment gross	2,818	2,818
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property plant equipment gross	16,197	8,827
Software
Property, Plant and Equipment [Line Items]
Property plant equipment gross	2,071	507
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property plant equipment gross	1,356	746
Construction in progress
Property, Plant and Equipment [Line Items]
Property plant equipment gross	$ 5,081	$ 2,139

XML

Property, Plant, and Equipment, net - Narrative (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Depreciation and amortization	$ 0.8	$ 0.2	$ 2.1	$ 0.5

XML

Accrued liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Payables and Accruals [Abstract]
Payroll and payroll related expenses	$ 3,904	$ 2,250
Accrued professional fees	5,325	2,450
Accrued product warranty costs	903		$ 816
Accrued contract manufacturer costs	1,346		0
Accrued contract termination costs (Note 12)	2,430		0
Accrued Orten cancellation costs (Note 1)	1,617		0
Accrued severance	475		$ 0
Other accrued expenses	2,586	1,254
Accrued liabilities	$ 18,586	$ 6,770

XML

Investments in Equity Securities - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Cumulative unrealized gain			$ 0
Cumulative impairment			0
Investments in equity securities	$ 15,030		$ 4,948
Raven SR
Schedule of Equity Method Investments [Line Items]
Cumulative unrealized gain	12,530
Investments in equity securities		$ 2,500
Global NRG H2 Limited
Schedule of Equity Method Investments [Line Items]
Cumulative impairment	$ (2,448)
Equity Option | Raven SR
Schedule of Equity Method Investments [Line Items]
Investments in equity securities		8,500
Common Stock | Raven SR
Schedule of Equity Method Investments [Line Items]
Investments in equity securities		$ 6,500

XML

Investments in Equity Securities - Summary of equity securities (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Carrying value of equity securities:
Total initial cost basis					$ 4,948	$ 4,948
Equity Securities, FV-NI, Unrealized Gain (Loss) [Abstract]
Cumulative unrealized gain					0
Carrying amount, end of period	$ 15,030		$ 15,030		$ 4,948
Unrealized gains (losses):
Unrealized gain on equity securities	0	$ 0	12,530	$ 0
Cumulative impairment	0	0	(2,448)	0
Total unrealized gain and impairment on equity securities	$ 0	$ 0	$ 10,082	$ 0

XML

Short-term Investments - Schedule of short-term investments (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-Sale [Line Items]
Fair Value	$ 239,648	$ 0
Short-Term Investments
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	239,548
Unrealized Gains	375
Unrealized Losses	(275)
Fair Value	239,648
Short-Term Investments | Certificates of deposit
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	105,097
Unrealized Gains	175
Unrealized Losses	(87)
Fair Value	105,186
Short-Term Investments | Commercial paper
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	47,197
Unrealized Gains	105
Unrealized Losses	0
Fair Value	47,302
Short-Term Investments | Corporate debt securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	39,780
Unrealized Gains	0
Unrealized Losses	(181)
Fair Value	39,598
Short-Term Investments | Foreign government bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	3,187
Unrealized Gains	0
Unrealized Losses	0
Fair Value	3,187
Short-Term Investments | U.S. Treasury bills
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	44,287
Unrealized Gains	95
Unrealized Losses	(7)
Fair Value	$ 44,375

XML

Short-term Investments - Narrative (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-Sale [Line Items]
Cash equivalents:	$ 40,600,000	$ 0
Short-Term Investments
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost		$ 0

XML

Income Taxes (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense	$ 0	$ 0	$ 526,000	$ 0
Deferred tax assets net	43,200,000		43,200,000		$ 23,000,000
Unrecognized tax benefit	0		0		0
Accrued interest and penalties	$ 0		$ 0		$ 0

XML

Fair Value Measurements - Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis (Detail) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Assets:
Cash equivalents:	$ 40,600,000	$ 0
Fair Value, Recurring
Liabilities:
Earnout shares liability	16,390,000	103,761,000
Fair Value, Recurring | Level 1
Liabilities:
Earnout shares liability	0	0
Fair Value, Recurring | Level 2
Liabilities:
Earnout shares liability	0	0
Fair Value, Recurring | Level 3
Liabilities:
Earnout shares liability	16,390,000	103,761,000
Fair Value, Recurring | Cash equivalents:
Assets:
Cash equivalents:	40,613,000
Fair Value, Recurring | Cash equivalents: | Level 1
Assets:
Cash equivalents:	16,330,000
Fair Value, Recurring | Cash equivalents: | Level 2
Assets:
Cash equivalents:	24,283,000
Fair Value, Recurring | Cash equivalents: | Level 3
Assets:
Cash equivalents:	0
Fair Value, Recurring | Certificates of deposit
Assets:
Short-term investments:	105,186,000
Fair Value, Recurring | Certificates of deposit | Level 1
Assets:
Short-term investments:	0
Fair Value, Recurring | Certificates of deposit | Level 2
Assets:
Short-term investments:	105,186,000
Fair Value, Recurring | Certificates of deposit | Level 3
Assets:
Short-term investments:	0
Fair Value, Recurring | Commercial paper
Assets:
Short-term investments:	47,302,000
Fair Value, Recurring | Commercial paper | Level 1
Assets:
Short-term investments:	0
Fair Value, Recurring | Commercial paper | Level 2
Assets:
Short-term investments:	47,302,000
Fair Value, Recurring | Commercial paper | Level 3
Assets:
Short-term investments:	0
Fair Value, Recurring | Corporate debt securities
Assets:
Short-term investments:	39,598,000
Fair Value, Recurring | Corporate debt securities | Level 1
Assets:
Short-term investments:	0
Fair Value, Recurring | Corporate debt securities | Level 2
Assets:
Short-term investments:	39,598,000
Fair Value, Recurring | Corporate debt securities | Level 3
Assets:
Short-term investments:	0
Fair Value, Recurring | Foreign government bonds
Assets:
Short-term investments:	3,187,000
Fair Value, Recurring | Foreign government bonds | Level 1
Assets:
Short-term investments:	0
Fair Value, Recurring | Foreign government bonds | Level 2
Assets:
Short-term investments:	3,187,000
Fair Value, Recurring | Foreign government bonds | Level 3
Assets:
Short-term investments:	0
Fair Value, Recurring | U.S. Treasury bills
Assets:
Short-term investments:	44,375,000
Fair Value, Recurring | U.S. Treasury bills | Level 1
Assets:
Short-term investments:	44,375,000
Fair Value, Recurring | U.S. Treasury bills | Level 2
Assets:
Short-term investments:	0
Fair Value, Recurring | U.S. Treasury bills | Level 3
Assets:
Short-term investments:	0
Fair Value, Recurring | Private Placements Warrants
Liabilities:
Warrant liability – Private Placement Warrants	1,843,000	15,228,000
Fair Value, Recurring | Private Placements Warrants | Level 1
Liabilities:
Warrant liability – Private Placement Warrants	0	0
Fair Value, Recurring | Private Placements Warrants | Level 2
Liabilities:
Warrant liability – Private Placement Warrants	1,843,000	15,228,000
Fair Value, Recurring | Private Placements Warrants | Level 3
Liabilities:
Warrant liability – Private Placement Warrants	$ 0	$ 0

XML

Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurement Inputs (Detail) - Earnout shares liability	Sep. 30, 2022 yr	Dec. 31, 2021 yr
Stock price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and rights outstanding, measurement input	1.70	6.49
Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and rights outstanding, measurement input	0.042	0.012
Volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and rights outstanding, measurement input	0.980	0.900
Remaining term (in years)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and rights outstanding, measurement input	3.79	4.54

XML

Fair Value Measurements - Summary of the Changes in the Liability for Private Placement Warrants (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Private placement warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance as of December 31, 2021	$ 15,228
Change in estimated fair value	(13,385)
Balance as of September 30, 2022	1,843
Earnout shares liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance as of December 31, 2021	103,761
Change in estimated fair value	(87,371)
Balance as of September 30, 2022	$ 16,390

XML

Commitments and Contingencies (Details) € in Millions, $ in Millions		1 Months Ended			7 Months Ended
	May 31, 2022 stockholder	Apr. 28, 2023 EUR (€)	Apr. 28, 2023 USD ($)	Jan. 14, 2022 lawsuit	Aug. 22, 2022 stockholder	Nov. 15, 2021 lawsuit
Long-Term Purchase Commitment [Line Items]
Number of class action lawsuits | lawsuit						3
Number of shareholder lawsuits | lawsuit				3
Number Of Stockholders, Demand For Books And Records | stockholder					4
Number Of Stockholders, Not Filing Complaint | stockholder	1
Subsequent Event
Long-Term Purchase Commitment [Line Items]
Payments for legal settlements		€ 2.1	$ 2.0

XML

Stock-based Compensation Plans - Summary of Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Weighted Average Remaining Contractual (Years)
Vested and expected to vest (in years)	11 years 8 months 26 days
Exercisable and vested (in years)	12 years 6 months 14 days
Stock options
Number of Options
Outstanding beginning balance (in shares) | shares	19,311,140
Granted (in shares) | shares	539,292
Exercised or released (in shares) | shares	(38,868)
Forfeited/Cancelled (in shares) | shares	(83,284)
Outstanding ending balance (in shares) | shares	19,728,280	19,311,140
Vested an expected to vest (in shares) | shares	14,190,780
Exercisable and vested (in shares) | shares	12,410,743
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 1.29
Granted (in dollars per share) | $ / shares	4.64
Exercised or released (in dollars per share) | $ / shares	1.13
Forfeited/Cancelled (in dollars per share) | $ / shares	1.13
Outstanding, ending balance (in dollars per share) | $ / shares	1.51	$ 1.29
Vested and expected to vest (in dollars per share) | $ / shares	1.21
Exercisable and vested (in dollars per share) | $ / shares	$ 1.13
Weighted Average Remaining Contractual (Years)
Outstanding, (in years)	12 years 2 months 1 day	13 years 25 days
Aggregate Intrinsic Value (in 000s)
Outstanding, beginning balance | $	$ 100,885
Outstanding, ending balance | $	8,054	$ 100,885
Vested and expected to vest | $	8,054
Exercisable and vested | $	$ 7,091
Restricted stock units
Number of RSUs
Outstanding, beginning balance (in shares) | shares	2,538,187	1,852,685
Granted (in shares) | shares	1,260,408
Exercised or released (in shares) | shares	(468,778)
Forfeited/Cancelled (in shares) | shares	(106,128)
Outstanding, ending balance (in shares) | shares	2,538,187	1,852,685
Vested and expected to vest (in shares) | shares	2,538,187
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 4.86	$ 6.14
Granted (in dollars per share) | $ / shares	3.72
Exercised or released (in dollars per share) | $ / shares	6.79
Forfeited/Cancelled (in dollars per share) | $ / shares	5.15
Outstanding ending balance (in dollars per share) | $ / shares	4.86	$ 6.14
Vested and expected to vest (in dollars per share) | $ / shares	$ 4.86

XML

Stock-based Compensation Plans - Narrative (Detail) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense related to earnout awards	$ (0.1)	$ 0.8
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense related to unvested stock options	11.1	$ 11.1
Weighted average recognition period of stock-based compensation expense		3 years 1 month 2 days
Restricted stock units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period for RSUs		4 years
Restricted stock units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period for RSUs		5 years
Performance and Market Based Vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense related to earnout awards		$ 0.0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense related to unvested stock options	$ 2.7	$ 2.7
Weighted average recognition period of stock-based compensation expense		3 years 6 months

XML

Stockholders' Equity (Details) $ / shares in Units, $ in Thousands		1 Months Ended	9 Months Ended
	Jan. 05, 2022 shares	Dec. 31, 2021 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) vote $ / shares shares	Nov. 17, 2021 USD ($)	Jul. 16, 2021 $ / shares
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		400,000,000	400,000,000
Common stock, par value (dollars per share) | $ / shares		$ 0.0001	$ 0.0001		$ 0.0001
Votes per Class A share | vote			1
Common stock, shares issued (in shares)		247,758,412	248,153,362
Common stock, shares outstanding (In shares)		247,758,412	248,153,362
Class of warrant or right, outstanding (in shares)		19,300,742	19,028,165
Amount authorized for repurchase | $				$ 5,000
Public warrants
Class of Stock [Line Items]
Class of warrant or right, outstanding (in shares)		11,286,242	11,013,665
Public warrants repurchased (in shares)	272,577	256,977	15,600
Cost of public warrants repurchased | $		$ 500	$ 31
Private Placement Warrants
Class of Stock [Line Items]
Class of warrant or right, outstanding (in shares)		8,014,500	8,014,500
Ardour warrants
Class of Stock [Line Items]
Class of warrant or right, outstanding (in shares)		275,048	170,048
Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)			400,000,000
Common stock, par value (dollars per share) | $ / shares			$ 0.0001
Common stock, shares issued (in shares)		247,758,412	248,153,362
Common stock, shares outstanding (In shares)		247,758,412	248,153,362

XML

Related Party Transactions (Detail) € in Millions, $ in Millions	1 Months Ended					3 Months Ended		4 Months Ended	9 Months Ended		12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2022 EUR (€)	Feb. 28, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2021 EUR (€)	Sep. 30, 2022 USD ($) vehicle	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) vehicle	Dec. 31, 2021 EUR (€)	Jan. 31, 2021 USD ($)
Related Party Transaction [Line Items]
Compensation cost						$ 0.4	$ 1.2		$ 0.9	$ 1.8
Related party liability				$ 3.7		0.1		$ 3.7	0.1		$ 3.7
Net related party receivable				0.3		$ 0.3		0.3	0.3		$ 0.3
Number of vehicles | vehicle						20					62
Hyzon Europe
Related Party Transaction [Line Items]
Cash consideration paid				1.1	€ 1.0
Hyzon Europe | Subsequent Event
Related Party Transaction [Line Items]
Remaining percentage ownership acquired	49.50%	49.50%
Cash consideration paid	$ 3.7	€ 3.5
Intellectual Property
Related Party Transaction [Line Items]
Horizon IP agreement payable													$ 10.0
Licensing Agreements
Related Party Transaction [Line Items]
Cost of intellectual property acquired			$ 3.1					6.9	$ 10.0
Hyzon Automotive Technology Company Limited | Hyzon Europe | Subsequent Event
Related Party Transaction [Line Items]
Ownership interest	100.00%	100.00%
Joint Venture Agreement | Hyzon Europe
Related Party Transaction [Line Items]
Ownership percentage in equity method investment						50.50%			50.50%
Executive Officer
Related Party Transaction [Line Items]
Payments to related party						$ 0.1	$ 0.1		$ 0.4	$ 0.3
Fuel Cell Technologies
Related Party Transaction [Line Items]
Prepaid expense						$ 6.0			$ 6.0
Letter Of Intent | Joint Venture Agreement
Related Party Transaction [Line Items]
Refundable deposit				$ 1.1				$ 1.1			$ 1.1	€ 1.0
Letter Of Intent | Joint Venture Agreement | Hyzon Motors, Inc. | Hyzon Europe
Related Party Transaction [Line Items]
Ownership percentage in equity method investment after increase				75.00%				75.00%			75.00%	75.00%

XML

Income (Loss) per share - Schedule of Earnings Per Share, Basic and Diluted (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Net income (loss) attributable to Hyzon	$ (24,795)	$ 34,621	$ 35,476	$ (17,568)	$ 10,681	$ 17,053
Weighted average shares outstanding:
Basic (in shares)	248,164,000	234,091,000			248,054,000	189,101,000
Effect of dilutive securities (in shares)	0	12,389,000			9,774,000	11,883,000
Diluted (in shares)	248,164,000	246,480,000			257,828,000	200,984,000
Net income (loss) per share attributable to Hyzon:
Basic (dollars per share)	$ (0.10)	$ 0.15			$ 0.04	$ 0.09
Diluted (dollars per share)	$ (0.10)	$ 0.14			$ 0.04	$ 0.08

XML

Income (Loss) per share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	2,538	426	937	426
Stock options with service conditions
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	12,419	0	539	0
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	5,538	5,538	5,538	5,538
Stock options | Former Chief Technology Officer
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	1,772	0	0	0
Warrant | Private placement warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	8,015	8,015	8,015	8,015
Warrant | Public warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	11,014	11,286	11,014	11,286
Warrant | Hongyun warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	31	0	31	0
Warrant | Ardour warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	170	326	0	326
Earnout shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	23,250	23,250	23,250	23,250

XML

Subsequent event (Details) - Subsequent Event - USD ($) shares in Millions, $ in Millions		1 Months Ended
	Dec. 21, 2022	Dec. 31, 2022
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Hyzon Guangdong Disposal Group
Subsequent Event [Line Items]
Proceeds from divestiture		$ 3.1
Difference between consideration received and book value		$ 0.5
Share buyback agreement (in shares)		3.8
Amount related to equity transfer agreement		$ 6.4
Share buyback agreement, cash paid for intercompany balances		3.3
Share buyback agreement, cash paid		$ 3.1
Chevron New Energies | Equity Capital Contribution Agreement "Raven Agreement"
Subsequent Event [Line Items]
Purchase price	$ 8.5
Forecast | Equity Capital Contribution Agreement "Raven Agreement"
Subsequent Event [Line Items]
Ownership percentage in equity method investment		20.00%
Forecast | Chevron New Energies | Equity Capital Contribution Agreement "Raven Agreement"
Subsequent Event [Line Items]
Purchase price		$ 1.5